9497

CURRICULUM VITAE Juan R.
Sanchez-Ramos
Date: March, 2016
PERSONAL
Name: JUAN R. SANCHEZ-RAMOS
Marital Status: married (Catherine), three children (Zachary age 31, Zoe age 28, Sofia age
25)
Office Address: Home Address:

Faculty Office Bldg/Dept of Neurology 6211 Quail Meadow Rd
13220 Laurel Drive Plant City, FL 33565
Tampa, FL 33612
Office phone: (813)974-5841 Home Phone: 813-986-9044

Cell phone: (813)300-2993 e-mail: jsramos@health.usf.edu
Current academic rank: Professor Primary Department: Neurology

Helen Ellis Endowed Chair for 2ary appointments: Dept of Molecular
Parkinson’s Disease Research; Pharmacology and Physiology
Vice Chair for Research Dept of Neurology
Citizenship: USA
HIGHER EDUCATION
Institutional:
University of Chicago, the college.......BS 1967 (Biological Sciences)
University of Chicago, Dept. of

Pharmacological and Physiological
Sciences..............................................PhD 1976 (Behavioral Pharmacology)
Thesis title: Opiate Agonist and Antagonist Interactions in the Morphine Dependent Rhesus
Monkey
University of Illinois, College of Medicine, Chicago............MD 1981 (Medicine)
Non-institutional: none
Certification, licensure: Licensed Physician in States of Illinois (inactive) and Florida (ME-
0047064); Diplomate of the American Board of Psychiatry and Neurology (1987)
1
CURRICULUM VITAE Juan R. Sanchez-Ramos
EXPERIENCE
Academic:
1976-77: Research Associate in Dept of Psychology, University of Ottawa
1977-78: Research Associate in Dept. of Pharmacological and Physiological Sciences
University of Chicago
1981-82: Medical Internship, Michael Reese Hospital, Chicago, Il
1982-85: Neurology Resident, University of Chicago
1985-87: Fellowship in Movement Disorders, Dept of Neurology, University of Miami
1987-1992: Assistant Professor Dept of Neurology, University of Miami
1991-1996 GRECC staff member, Miami VA Medical Center
1992-1994: Associate Director of Clinical Research, Comprehensive Drug Research Center
1992-1996: Associate Professor Dept of Neurology (with tenure), University of Miami
1996- : Helen E. Ellis Professor of Neurology, University of South Florida, Tampa FL
1999- 2006: Director of Confocal Microscopy Laboratory, James Haley VA Hospital
2004- 2006: Director of Cell Therapy Research Workgroup
2004- 2009: Member of Florida Alzheimer’s Disease Research Center
2006- : Vice-Chairman for Research, Dept of Neurology
2006-2009: Charter Member NIH Study Section (CNNT)
2008- : Medical Director, Parkinson Research Foundation, Sarasota, FL
Non-academic:
1967-70: Free-lance graphic artist; fine art exhibitions in Copenhagen, Denmark; Chicago,
Illinois, and Santo Domingo, Dominican Republic
1972-1975: Art Editor, Chicago Review
PUBLICATIONS
A. BOOK CHAPTERS
1. Hefti, F., Hartikka J., and Sanchez-Ramos, J.. Cholinergic neurons of the basal
forebrain in culture. In, "Cell Culture Techniques in Neurobiology", Eds. A. Shahar and B.
Haber Alan Liss, NY., 1989
2. Sanchez-Ramos J and Weiner WJ. Iatrogenic Movement Disorders, In "Neurology for

the Non-Neurologist", Ed. WJ Weiner, Lippincott, N.Y. pp 121-131, 1988
3. Sanchez-Ramos, J. Neurological Emergencies Related to Drugs of Dependence, In,

Urgent and Emergent Neurology Ed. W. J. Weiner, Lippincott, Philadelphia, pp 487-508, 1991
4. Sanchez-Ramos, J and Weiner WJ. Drug-induced tics. In Handbook of Tourette's

Syndrome and Related Tic and Behavioral Disorders (Ed. R. Kurlan) Marcel Dekker, Inc. 1992
5. Sanchez-Ramos, J. and Weiner W. J. Other Dopaminergic Drug-induced Movement

Disorders. In:Drug-Induced Movement Disorders (Ed. WJ Weiner and A. Lang) Futura Press,
Mt Kisco NY, 1992
2
6. Sanchez-Ramos, J. Toxin-induced parkinsonism. In: Parkinsonian syndromes (Ed. M.

Stern, WC Koller), Raven Press, NY, pp-155-171, 1992
7. Sanchez-Ramos, J. Psychostimulants. In, Neurologic Clinics, Neurologic

Complications of Drug and Alcohol Abuse.(Ed) J. Brust. WB Saunders, NY 11:(3)535-553.
1993
8. Sanchez-Ramos, J., Penney, J., Young, A.B. Wexler N., and Shoulson I. Huntington's
Disease. In, Tropical Neurology (Ed. Roman G.)
9. Globus MYT, Prado R, Sanchez-Ramos J, Dietrich WD, Ginsberg MD, Busto R.

Excitotoxic and ischemic damage: role of nitric oxide. In, Pharmacology of Cerebral Ischemia
(Eds J Krieglstein, H Oberpichler-Schwenk) Wissenschaftliche Verlagsgesellschaft Stuttgart,
1994, pp363-373
10. Shulman LM, Sanchez-Ramos J, Weiner WJ. Stereotyped Behavior in Movement

Disorders In, Sprague RL and Newell KM (eds). Stereotypies: Brain-Behavior Relationships,
1996
11. Sanchez-Ramos, J. and Mash D. Pharmacotherapy of drug dependence with ibogaine.

In, Constructive Potentials of Psychedelics: Cross-cultural perspectives (Ed) M. Winkelman, W
Andritzky). Yearbook of Cross-Cultural Medicine and Psychotherapy Volume 4, 1996
12. Sanchez-Ramos, J. Neurological Complications of Drugs of Abuse, In Neurology in

Clinical Practice. (Ed) Bradley WG, Daroff RB, Fenichel GM, Marsden CD) Butterworth-
Heinemann pp 1402-1414, 1996
13. Sanchez-Ramos, J. High dose pergolide therapy in the treatment of severe

dyskinesias in Parkinson’s disease. In, Beyond Decade of the Brain, Vol 2 Dopamine Agonists
in early Parkinson’s disease. (Eds. C. Warren Olanow, J. A. Obeso) Wells Medical Limited,
Kent, UK. pp 217-221, 1997
14. Sanchez-Ramos, J. Motor Complications of Levodopa therapy, In, Parkinson’s

Disease. (Ed. M. Merello, AJ. Lees) published by Talleres Graficos de “La Ley” S.A.E., Buenos
Aires, Argentina 1999
15. Mash DC, Kovera CA, Buck BE, Norenberg MD, Phapshak P, Hearn WL, Sanchez-
Ramos J. Medication development of ibogaine as a pharmacotherapy for drug dependence.
In. The Neurology of Drugs of Abuse Cocaine, Ibogaine and Substituted Amphetamines (Ed.
Syed Ali) Annals NY Acad Sci, 275-292, 1998
3
16. Song S, Sanberg P and Sanchez-Ramos J. The Search for Neural Progenitors in
Bone Marrow and Umbilical Cord Blood In, Neural Stem Cells. Edited by T. Zigova and P.
Sanberg Methods in Molecular Biology Humana, Totowa, NJ., 2002
17. Song S, and Sanchez-Ramos J. Preparation of Neural Progenitors from Bone Marrow
and Umbilical Cord Blood. Methods in Molecular Biology Vol 198:79-88 Protocols for Neural
Stem Cell Methods (Edited by T. Zigova, P. Sanberg, and J. Sanchez-Ramos). Humana
Press, Totowa, NJ, 2002
18. Sanchez-Ramos J. Stimulant-Induced Movement Disorders, In, Drug-Induced

Movement Disorders. Ed. K. Sethi, Marcel Dekker, Inc. New York, Basel. 2004
19. Carroll, E and Sanchez-Ramos J. Hyperkinetic Movement Disorders Associated with

HIV and other Viral Infections, In Handbook of Clinical Neurology (series 3) Movement
Disorders Volume, Ed. Weiner and Tolosa. Vol 100, 323-334, 2011
20. Sanchez-Ramos, J. Discrepancy in CAG Repeat Lengths in a Case of Clinically

Manifest Huntington’s Disease. In Movement Disorders: Unforgettable Cases and Lessons
from the Bedside Ed. H. H. Fernandez and M Merello Demos Medical, NY 2012
21. O’Neill C and Sanchez-Ramos J. Cannabinoids for the treatment of Movement

Disorders in The Pot Book edited by Julie Holland MD. 2013
http://www.thepotbook.com/potbook/additional_chapters.html
B. SCIENTIFIC ARTICLES IN REFEREED JOURNALS
22. Sanchez-Ramos, J. and Schuster, C.R. Second Order schedules of intravenous drug
self-administration in the rhesus monkey. Pharm. Biochem. Behav. 7:443-450, 1977
23. Sanchez-Ramos, J., Diab, I.M., Wainer, B., Dinerstein, R.J., and Roth, L.J. An artifact
of liquid emulsion autoradiography. Stain Tech. 53: 163-167, 1978
24. Stretch, R. and Sanchez-Ramos, J.Effects of morphine, naloxone, and

diallylnormorphine upon behavior maintained by electric shock postponement in squirrel
monkeys. Can. J. Physiol. Pharmacol. 57: 98-105, 1979
25. Sanchez-Ramos, J. and Senay, E. Ophthalmic naloxone elicits abstinence in

opioid-dependent subjects. Brit. J. Addict., 82:313-315, 1986
26. Sanchez-Ramos, J., Barrett, M. Goldstein, J.N., Weiner, W.J., and Hefti, F.
Methyl-phenylpyridinium (MPP+), but not 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine
(MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat
mesencephalic cells. Neurosci. Lett. 72, 215-220, 1986
4
27. Factor, S., Sanchez-Ramos, J., and W.J. Weiner. A double blind evaluation of Cilodopa
in Parkinson's Disease. Movement Disorders 2:211-217, 1987
28. Sanchez-Ramos, J., G. E. Hollinden, T. J. Sick, and M. Rosenthal. MPP+ increases

oxidation of cytochrome b in rat striatal slices. Brain Res.443:183-189, 1988
29. Factor, S.A., Sanchez-Ramos, J., and Weiner, W.J. Trauma as an etiology of
parkinsonism: a historical review of the concept. Movement Disorders, 3:30-36, 1988
30. Sanchez-Ramos J, Michel P, Weiner WJ, Hefti F. Selective Destruction of Cultured

Dopaminergic Neurons From Fetal Rat Mesencephalon by MPP+: Cytochemical and
Morphological Evidence J. Neurochemistry, 50: 1934-1945, 1988
31. Factor, S.A., Sanchez-Ramos, J. and Weiner, W.J.Parkinson's disease: An open label
trial of pergolide in patients failing bromocriptine therapy. J. Neurol. Neurosurg. Psychiat.,
51:529-533, 1988
32. Factor SA, Sanchez-Ramos J, Weiner WJ. Delayed Onset Dystonia Associated with
Cortico-spinal Tract Dysfunction. Movement Disorders, 3: 201-210, 1988
33. Hollinden GE, Sanchez-Ramos J, Sick TJ, Rosenthal M MPP+ increases extracellular
potassium in rat striatal slices: preliminary evidence that consequences of MPP+ neurotoxicity
are spread beyond dopaminergic terminals. Brain Research 475: 283-290, 1988
34. Michel P.P., Dandapani, B. K., Sanchez-Ramos J., Efange S, Pressman B, Hefti F.
Toxic Effects of potential environmental neurotoxins related to MPP+ on cultured rat
dopaminergic neurons. J. Pharmacol. Exp. Ther., 248:842-850, 1989
35. Factor SA, Sanchez-Ramos J, Ingenito AM, Weiner WJ. Efficacy of Sinemet CR4 in
Subgroups of patients with Parkinson's Disease. J. Neurol Neurosurg Psychiat,52:83-88, 1989
36. Weiner, W.J., Factor, S.A., and Sanchez-Ramos, J. The efficacy of

(+)-4-propyl-9-hydroxynapthoxazine (PHNO) in Parkinson's disease. J Neurol Neurosurg
Psychiat 52: 732-735, 1989
37. Sanchez-Ramos J, Factor SA, Weiner WJ. Hemichorea-ballismus associated with

AIDS and Cerebral Toxoplasmosis: a case report. Movement Disorders 4:261-265, 1989
38. Hollinden, G.E., Sanchez-Ramos, J., Sick, T.J. and Rosenthal, M. MPP+-induced
pathophysiology demonstrates advantages of neurotoxicology studies in brain slices. J
Neurosci Meth 128:51-57, 1989
39. Singer, C., Sanchez-Ramos, J., and Weiner, W. J. A case of post-traumatic tic disorder.
Movement Disorders 4:342-344, 1989
5
40. Penney, J.B., Jr., Young, A. B., Shoulson, I, Starista- Rubinstein, S, Snodgrass, R,
Sanchez-Ramos, J. et al., Huntington's Disease in Venezuela: 7 years of follow-up on
symptomatic and asymptomatic individuals. Movement Disorders 5:93-99, 1990
41. Michel, P.P, Dandapani, B.K. Knusel, B., Sanchez-Ramos, J., and Hefti, F. Toxicity of
+
MPP for rat dopaminergic neurons in culture: selectivity and irreversibility. J. Neurochem
54:1102-1109, 1990
42. Irwin CC, Wexler NS, Young AB, Ozelius LJ, Penney JB, Shoulson I, Snodgrass R,
Ramos-Arroyo MA, Sanchez-Ramos J, Penchaszadeh GK, Bonilla E, Conneally PM, Gusella
JF. The Role of Mitochondrial DNA in Huntington's Disease. J Mol Neurosci 1:129-136, 1989
43. Singer C, Weiner WJ, Sanchez-Ramos J, Ackerman M. Sexual dysfunction in men with
Parkinson's disease. J. Neuro Rehab. 3:189-204, 1989
44. Factor SA, McAlarney T, Sanchez-Ramos J, Weiner WJ. Sleep Disorders and Sleep
Effect in Parkinson's Disease. Movement Disorders 5:280-285, 1990
45. Singer, C., Sanchez-Ramos, J.. and Weiner, W.J. Levodopa responsive parkinsonism
in a patient with Down's syndrome. Eur. Neurol 30:247-248, 1990
46. Sanchez-Ramos, J. Banisterine and Parkinson's Disease. Clinical Neuropharm

14:391-402, 1991
47. Martin, F. R., Sanchez-Ramos, J., Rosenthal, M. Selective and nonselective effects of
MPP+ on oxygen consumption in rat striatal and hippocampal slices. Brain Research, 57:1340-
1346, 1991
48. Mash DC, Pablo J, Sanchez-Ramos J, Weiner WJ. Distribution of transferrin receptors
in Parkinson's disease and in MPTP- treated mice. Exp Neurol 114:73-81, 1991
49. Sanchez-Ramos J, Song S, Mash DC, Weiner WJ. 21- aminosteroids interact with the
dopamine transporter to protect against MPP +-induced neurotoxicity. J Neurochem, 58:328-
334, 1992
50. Singer C, Weiner WJ, Sanchez-Ramos, J.. Autonomic dysfunction in men with
Parkinson's Disease. Eur Neurol 32:134-140, 1992
51. Weiner WJ, Factor SA, Sanchez-Ramos J, Singer C, Sheldon C, Cornelius L, Ingenito
A. Early combination therapy (bromocriptine and levodopoa) does not prevent motor
fluctuations in Parkinson's Disease. Neurology 43:21-27,1993
52. Weiner WJ, Singer C, Sanchez-Ramos J, Goldenberg JN. Levodopa, melanoma, and
Parkinson's disease. Neurology 43:674-677,1993
6
53. MacDonald ME, Barnes G, Srinidhi J et al (and Sanchez-Ramos J.) Gametic but not
somatic instability of CAG repeat length in Huntington's Disease. J Med Genet 30:982-986,
1993
54. Duyao et al (with the USA-Venezuela HD group including Sanchez-Ramos, J.)

55. Trinucleotide repeat length: instability and age of onset in Huntington's Disease. Nature
Genetics, 4:387-392, 1993
56. Flynn DD, Sanchez-Ramos J. Mash DC. Perinatal cocaine exposure alters sigma
binding site density in the placenta. Res Commun Subst Abuse 14:17-36, 1993
57. Singer C, Sanchez-Ramos J., Weiner WJ. Gait abnormality in Essential Tremor
Movement Disorders 9:193-196, 1994
58. Fleming L, Mann JB, Briggle T, Sanchez-Ramos J. Organochlorine pesticides in

Parkinson's Disease Brain. Ann Neurology 36:100-103, 1994
59. Sanchez-Ramos J, Overvik E, Ames BN. A marker of oxyradical-mediated DNA

damage (oxo8dG) is increased in Nigro-Striatum of Parkinson's Disease Brain
Neurodegeneration 3:197-204, 1994
60. Bowen B, Block RE, Sanchez-Ramos J, Pattany PM, Quencer RM. Parkinson's
Disease: Proton Spectroscopy of the Brain In Vivo. Am J Neuroradiol 16:61-68, 1995
61. Verma A, Berger J, Sanchez-Ramos J Reversible Parkinsonian Syndrome Associated

with Cysticercus Midbrain Encephalitis. Movement Disorders 10: 215-219, 1995
62. Rey GJ, Tomer, R, Levin BE, Sanchez-Ramos J, Bowen B, and Bruce JH. Psychiatric
symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic
degeneration. Movement Disorders 10:106-110, 1995
63. Molho ES, Factor SA, Weiner WJ, Sanchez-Ramos J, Singer C, Shulman LM, Brown
D, Sheldon C. The use of pramipexole, a novel dopamine agonist, in advanced Parkinson's
Disease. J Neural Trans 45: 225-230, 1995
64. Mash, D.C., Douyon, R., Hearn, W.L., Sambol, N.C. and Sanchez-Ramos, J. A
Preliminary Report on the Safety and Pharmacokinetics of Ibogaine. Biol Psychiat 37:652,
1995.
65. Facca A, and Sanchez-Ramos, J. Pergolide monotherapy in complicated Parkinson's

Disease. Movement Disorders 11(3):327-329, 1996
66. Sanchez-Ramos J, Ortoll R, Paulson G. Visual hallucinations in Parkinson's disease

Arch Neurol 53(12):165-1268, 1996
7
67. Sanchez-Ramos J, Song S, Basit A, Epstein CJ. Transgenic Murine Dopaminergic

Neurons Expressing Human Cu/Zn Superoxide Dismutase Exhibit Increased Density in
Culture, But No Resistance to MPP+-induced Degeneration. J Neurochem 68: 58-67,1997
68. Sanchez-Ramos J. Facca A, Basit A, Song S. Toxicity of dieldrin for dopaminergic

neurons in mesencepahlic cultures. Exp Neurol 150:263-271,1998
69. Cardozo-Pelaez F, Song S, Parthasarathy A, Epstein CJ, Sanchez-Ramos, J.

Attenuation of age-dependent oxidative damage to DNA and protein in brainstem of tg Cu/Zn
SOD mice. Neurobiology of Aging 19(4):311-316, 1998
70. Cardozo-Pelaez F, Song S, Parthasarathy A, Naidu K, Sanchez-Ramos, J. Oxidative

DNA Damage in the Aging Mouse Brain. Movement Disorders, 14:972-980, 1999
71. Khema R. Sharma, Jose G. Romano, D. Ram Ayyar, Francisco T. Rotta, Alicia Facca,
Juan Sanchez-Ramos. Sympathetic Skin Response and Heart Rate Variability in Patients
with Huntington’s Disease. Archives of Neurology 56:1248-1252, 1999..
72. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A,.

Freeman T, Saporta S, Janssen W, Patel N, Cooper D.R., and Sanberg P.R. Adult Bone
Marrow Stromal Cells Differentiate Into Neural Cells in vitro Exp. Neurol 2000:164,247-256
73. Sanchez-Ramos J, S. Song, M. Dailey, F. Cardozo-Pelaez, C. Hazzi, T. Stedeford, A.

Willing, T. B. Freeman, S. Saporta, T. Zigova, P. R. Sanberg, and E. Y. Snyder. The X-gal
Caution in Neural Transplantation Studies. Cell Transplantation 9:657-667,2000
74. Sanchez-Ramos J, S Song, M. Daadi, P. R. Sanberg. The Potential of Bone Marrow

as a Source of Neural Precursors. Neuroscience News 3(6)32-43,2000
75. Stedeford T, Cardozo-Pelaez F, Hover C, Harbison RD, and Sanchez-Ramos J.

Organ-specific differences in 8-oxo-guanosine glycosylase (OGG1) repair following acute
treatment with benzo[a}pyrene. Res Com Mol Path Pharm. 109(1&2), 2001
76. Kruman, II, Cardozo-Pelaez, F., Kumaravel, T. S., Stedeford, T. J., Lohani, A., Evans,
M., Sanchez-Ramos, J. R., and Mattson, M. P., Folate deficiency is neurotoxic and potentiates
oxidative stress by impairing DNA repair in models of Alzheimer's disease. Molecular Biology
of the Cell 12, 137, 2001
77. Zigova T, Willing A, Saporta S, Daadi M, McGrogan MP, Randall TS, Freeman TB,
Sanchez-Ramos JR and Sanberg PR. Apoptosis in Cultured hNT Neurons. Dev Brain Res
127:63-70, 2001
78. Serrano-Duenas M, F. Cardozo-Pelaez, J. Sanchez-Ramos. Effects of Banisteriopsis

Extracts on De Novo Parkinson’s Disease Patients. Scientific Rev of Alternative Medicine
3:127-132, 2001
8
79. Stedeford T, Cardozo-Pelaez F, N. Nemeth, Harbison, J. Sanchez-Ramos.

Comparison of Base-excision capacity in proliferating and differentiated PC 12 cells following
acute challenge with dieldren. Free Radical Biology and Medicine. 31(10):1272-1278, 2001
80. Stedeford, T., Cardozo-Pelaez, F., Hover, C., Harbison, R. D., and Sanchez-Ramos, J.,
Organ specific differences in 8-oxoguanosine glycosylase (OGG1) repair following acute
treatment with Benzo[a]pyrene. Research Communications in Molecular Pathology and
Pharmacology 109, 73-85, 2001
81. Sanchez-Ramos J, Song S, Kamath S, Zigova T, Willing A, Cardozo-Pelaez F,

Stedeford T, Chopp M, Sanberg P. Expression of Neural Markers in Human Umbilical Cord
Blood. Exp Neurol 171:109-115, 2001
82. Chen, J. Sanberg P. R. Li Y. Wang L. Lu M. Willing A. E. Sanchez-Ramos J., Chopp M

Intravenous administration of human umbilical cord blood reduces behavioral deficits after
stroke in rats. Stroke 32: 2682-2688, 2001
83. Lu, D., Sanberg, P. R., Mahmood, A., Li, Y., Wang, L., Sanchez-Ramos, J., and Chopp,
M., Intravenous administration of human umbilical cord blood reduces neurological deficit in
the rat after traumatic brain injury. Cell Transplantation 11, 275-281, 2002
84. Russo E, Mathre ML, Byrne A, Velin R, Bach PJ, Sanchez-Ramos J, and Kirlin KA.
Chronic Cannabis Use in the Compassionate Investigational New Drug Program: An
Examination of Benefits and Adverse Effects of Legal Clinical Cannabis. Journal of Cannabis
Therapeutics, 2(1): 3-57, 2002
85. Cardozo-Pelaez, F., Stedeford, T., Brooks, P.J., Song S., Sanchez-Ramos J. Effects of
Diethylmaleate on DNA Damage and Repair in the Mouse Brain. Free Radic Biol Med 33 (2)
292-298, 2002
86. Zigova T, Song S, Willing A.E., Hudson, J.E., Newman, M.B., Saporta, S., Sanchez-
Ramos, J. Sanberg, P.R.. Human umbilical cord blood cells express neural antigens after
transplantation into the developing rat brain. Cell Transplantation 11:265-274, 2002
87. Sanchez-Ramos, J. Neural Cells Derived from Adult Bone Marrow and Umbilical Cord
Blood. J. Neurosci. Res. 69:880-893, 2002
88. Newman, M. B., Sanberg, P. R., Sanchez-Ramos, J., Willing, A. E., Bickford, P. C.,
Manresa, J., and Zigova, T., Optimal culture conditions to study the properties of human
umbilical cord blood (HUCB) cells exposed to neuralizing agents. Experimental Neurology 175,
432-434.2002
89. Mosquera D, Stedeford T, Cardozo-Pelaez F, Sanchez-Ramos J Strain-Specific

Differences in the Expression and Activity of Ogg1 in the CNS. Gene Expression 11:47-53,
2003
9
90. Willing A.E, Vendrame M, Mallery , Cassady CJ, Hart CD, Sanchez-Ramos J, Sanberg
PR. Mobilized peripheral blood cells administered intravenously produce functional recovery in
stroke. Cell Transplantation 12: 2003
91. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, Hart C, Sanchez-Ramos J,
Sanberg P.R. Intravenous vs intrastriatal cord blood administration in a rodent model of stroke.
J. Neurosc. Res. 73:296-307, 2003
92. Song, S. and J. Sanchez-Ramos. Brain as a "Sea of Marrow" Exp. Neurol 184:54-
60,2003
93. Sava, V., Mosquera, D., Song, S., Stedeford, T., Calero, K., Cardozo-Pelaez, F.,
Harbison, R., and Sanchez-Ramos, J., 2003. Rubratoxin B elicits antioxidative and DNA
repair responses in mouse brain. Gene Expression 11, 211-219, 2003
94. Song, S. Kamath S, Mosquera D, Zigova T, Sanberg P, Vesely DL, Sanchez-

Ramos J. Expression Of Brain Natriuretic Peptide By Human Bone Marrow Stromal Cells Exp.
Neurol 185:, 191-197, 2004
95. V. Sava, D. Mosquera, S. Song, F. Cardozo-Pelaez, and J. Sanchez-Ramos Effects Of

Melanin and Manganese on DNA Damage and Repair in PC12-Derived Neurons. Free Rad
Bio Med 36 (9): 1144-1154, 2004
96. The US-Venezuela Collaborative Research Project (and J. Sanchez-Ramos)

"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's
disease age of onset" PNAS 101 (10) 3498-3503, 2004
97. Sava V, Mosquera D, Song S, Stedeford T, Calero K, Cardozo-Pelaez F, Sanchez-

Ramos. J. Rubratoxin B Elicits Antioxidative and DNA Repair Responses in Mouse Brain.
Gene Expression 2004; 11: 211-219.
98. Hudson, J. E., Chen, N., Song, S., Walczak, P., Jendelova, P., Sykova, E., Willing, A. E.,
Saporta, S., Bickford, P., Sanchez-Ramos, J., and Zigova, T. Green fluorescent protein bone
marrow cells express hematopoietic and neural antigens in culture and migrate within the
neonatal rat brain. J Neurosci Res 76: 255-264; 2004.
99. Walczak, P., Chen, N., Hudson, J. E., Willing, A. E., Garbuzova-Davis, S. N., Song, S.,
Sanberg, P. R., Sanchez-Ramos, J., Bickford, P. C., and Zigova, T. Do hematopoietic cells
exposed to a neurogenic environment mimic properties of endogenous neural precursors? J
Neurosci Res 76: 244-254, 2004.
100. Kamath, S. G., Chen, N., Enkemann, S. A., and Sanchez-Ramos, J., Transcriptional
profile of NeuroD1 expression in a human fetal astroglial cell line. Gene Expression 12, 123-
136., 2004
10
101. Vesely BA, Song S, Sanchez-Ramos J, Fitz SR, Solivan SM, Gower WR, Jr., et al.
Four peptide hormones decrease the number of human breast adenocarcinoma cells. Eur J
Clin Invest 35: 60-9, 2005.
102. Vesely BA, Song S, Sanchez-Ramos J, Fitz SR, Alli AA, Solivan SM, et al. Five cardiac
hormones decrease the number of human small-cell lung cancer cells. Eur J Clin Invest
2005;35(6):388-398.
103. Kamath SG, Chen N, Enkemann SA, Sanchez Ramos J. Transcriptional Profile of
NeuroD1 in a Human Fetal Astroglial Cell Line. Gene Expression 2005; 12, 123-126
104. Zesiewicz TA, Sanchez-Ramos J, Sullivan KL, Hauser RA. Levetiracetam-Induced

Parkinsonism in a Huntington Disease Patient. Clin Neuropharmacol 2005;28(4):188-190.
105. Chen N, Hudson JE, Walczak P, et al (includes Sanchez-Ramos, J). Human umbilical
cord blood progenitors: The potential of these hematopoietic cells to become neural cells.
Stem Cells 2005;23(10):1560-1570.
106. Vesely BA, Alli A, Song SJ, Sanchez-Ramos, J. Fitz SR, Gower WR, Vesely
DLPrimary malignant tumors of the heart: Four cardiovascular hormones decrease the number
and DNA synthesis of human angiosarcoma cells. Cardiology 2006;105(4):226-233.
107. Zesiewicz TA, Sullivan KL, Hauser RA, Sanchez-Ramos J. Open-label pilot study of
levetiracetam (Keppra) for the treatment of chorea in Huntington's disease. Mov Disord
2006;21(11):1998-2001.
108. Zesiewicz, TA, Ward, CL, Hauser RA, Sanchez-Ramos J, Staffetti J, Sullivan K. A
double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential
tremor Movement Disord 2007; 22 (2): 279-282
109. Sanchez-Ramos J. Stem cells from umbilical cord blood. Semin Reprod Med
2006;24(5):358-369.
110. Sava V, Reunova O, Velasquez A, Sanchez-Ramos J. Acute Neurotoxic Effects of the

Fungal Metabolite Ochratoxin-A. Neurotoxicology 27:82-92, 2006
111. Sava V, Reunova O, Velasquez A, Sanchez-Ramos J. Can low level exposure to

ochratoxin-A cause parkinsonism? J Neurol Sci 2006;249(1):68-75.
112. Sava V, Reunova O, Velasquez A, Song S, Sanchez-Ramos J. Neuroanatomical
mapping of DNA repair and antioxidative responses in mouse brain: Effects of a single dose of
MPTP. Neurotoxicology 2006; 27 (6):1080-1093
113. Sava V, Velasquez A, Song S, Sanchez-Ramos J. Adult Hippocampal Neural

Stem/Progenitor Cells In Vitro Are Vulnerable to the Mycotoxin Ochratoxin-A Toxicological
Sciences 2007 98(1):187-197
11
114. Sava V, Velasquez A, Song S, Sanchez-Ramos J. Dieldrin elicits a widespread DNA

repair and antioxidative response in mouse brain Journal of Biochemical and Molecular
Toxicology 2007; 21(3):125 – 135
115. Walczak, P, Author Walczak Piotr Walczak, Piotr , Chen, N, Hudson J, Zigova T,
Sanchez-Ramos J, Sanberg PR, Sanberg CD, and Willing AE. Long-term cultured human
umbilical cord neural-like cells transplanted into the striatum of NOD SCID Mice Brain Res Bull
2007; 74 (1-3): 155-163
116. Song, Shijie; Song, Shuojing; Zhang, Hongling; Cuevas, J; Sanchez-Ramos, J.

Comparison of Neurons Derived from Bone Marrow Stem Cells To Those Differentiated from
Adult Brain Neural Stem Cells. Stem Cells and Development 2007; 16(5): 747-756.
117. Sanchez-Ramos J, Song S, Cao C, Arendash G. The potential of hematopoietic

growth factors for treatment of Alzheimer's disease: a mini-review. BMC Neurosci 2008
Dec 3:9 suppl2:S3
118. Song S, Sanchez-Ramos, J. Preparation of neural progenitors from bone marrow and
umbilical cord blood. Methods Mol Biol 438: 123-134, 2008
119. Roscoe LA, Corsentiono E, Watkins S, McCall M, Sanchez-Ramos J Well-Being of

Family Caregivers of Persons with Late-Stage Huntington's Disease: Lessons in Stress and
Coping. Health Communication 24 (3) 239-248, 2009
120. Catlow BJ, Rowe AR, Clearwater CR, Mamcarz M, Arendash GW, Sanchez-Ramos J.
Effects of environmental enrichment and physical activity on neurogenesis in
transgenic PS1/APP mice. Brain Res. 1256: 173-179, 2009
121. Rowe A, Eberhard J, Sanchez-Ramos J. Hematopoietic growth factors: Novel

therapeutic strategy for Alzheimer's disease. Drugs of the Future.34:977-89, 2009
122. Catlow BJ, Badanich KA, Sponaugle AE, Rowe AR, Song S, Rafalovich I, Sava V,
Kirstein CL, Sanchez-Ramos J. Effects of MDMA ("ecstasy") during adolescence on
place conditioning and hippocampal neurogenesis. Eur J Pharamcol 628:96-103, 2009
123. Sanchez-Ramos J, Song S, Sava V, Catlow B, Dickson A, Lin X, Patel N, Mori T, Cao
C, Arendash GW. Granulocyte colony stimulating factor decreases brain amyloid burden and
reverses cognitive impairment in Alzheimer’s mice Neuroscience 163:55-72, 2009
124. Arendash GW, Sanchez-Ramos J, Mori T, Mamcarz M, Lin X, Rundfeldt M, Wang L,

Zhang G, Sava V, Tan J, Cao C. Electromagnetic Field Treatment Protects Against and
Reverses Cognitive Impairment in Alzheimer's Disease Mice J Alzheimers Dis 2009; 19:191-
210
12
125. Cheney ML, Shan N, Healey ER, Hanna M, Wotjas L, Zaworotko, Sava S, Song S and
Sanchez-Ramos, J. Effect of Crystal Form on Solubility and Pharmacokinetics: A Crystal
Engineering Case Study of Lamotrigine. Crystal Growth & Design 10:394-405, 2010
126. Apostolatos H, Apostolatos A, Vickers T, Watson JE, Song S, Vale F, Cooper DR,
Sanchez-Ramos J, and Patel NA. Vitamin A metabolite, all-trans retinoic acid, mediates
alternative splicing of protein kinase C delta(PKC )VIII isoform via the splicing factor SC35 J.
Biol. Chem. published June 14, 2010 as doi:10.1074/jbc.M110.100735 V 285, pp 25987-
25995
127. Butterfield, L.C., Cimino, C.R., Oelke, L.E., Hauser, R.A., Sanchez-Ramos, J., 2010.
The Independent Influence of Apathy and Depression on Cognitive Functioning in Parkinson's
Disease. Neuropsychology 24, 721-730.
128. Boyd, TD, Bennett, SP, Mori T, Governatori, N, Runfeldt M, Norden M, Padmanabhan J,
Neame P, Wefes I, Sanchez-Ramos J, Arendash GW, Potter H. GM-CSF upregulated in
rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. J
Alzheimers Dis 21 (2) 507-18, 2010
129. Song S, Sava V, Rowe A, Li K, Cao C, Mori T, and Sanchez-Ramos, J. Granulocyte-

colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson's disease
Neurosci Lett 487(2):153-.7, 2011
130. Sanchez-Ramos J, Reimer D, Zesiewicz T, Sullivan K, Nausieda PA. Quantitative

Analysis of Tremors in Welders Int. J. Environ. Res. Public Health 8: 1478-1490, 2011
131. Friedman et al (including J.Sanchez-Ramos) Clinical vignettes in Parkinson's disease:

a collection of unusual medication-induced hallucinations, delusions, and compulsive
behaviours. The International Journal of Neuroscience 121: 472-6, 2011
132. Sanchez-Ramos J, Cimino C, Avila R, Rowe A, Chen R, Whelan G, Lin X, Cao C,

Ashok R. Pilot Study of Granulocyte-colony stimulating factor for treatment of Alzheimer’s
Disease. Journal of Alzheimer’s Disease 31: 843–855, 2012
133. Shijie Song, Shuojing Song, Chuanhai Cao, Xiaoyang Lin, Kunyu LI, Vasyl Sava and J.
Sanchez-Ramos Hippocampal Neurogenesis and the Brain Repair Response Brief
Stereotaxic Insertion of a Micro-needle Stem Cells International 2013 Article ID 205878 14
pages http://dx.doi.org/10.1155/2013/205878
134. Shijie Song, Amanda Rowe, Kunyu Li, Vasyl Sava and J. Sanchez-Ramos
Neuroprotective effects of bone marrow stromal cells in cocultures of fetal dopaminergic
neurons. Journal of Neurodegeneration and Regeneration Fall 2013; pages 27-36
DOI:10.5055/jndr.2013.0010
135.
13
136. Briony Catlow, Shijie Song, Daniel Paredes, Cheryl Kirstein and J. Sanchez-Ramos
Effect of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.
Exp. Brain Research (2013) 228:481–491 DOI: 10.1007/s00221-013-3579-0
137. Velez-Lago FM, Thompson A, Oyama G, Hardwick A, Sporrer JM, Zeilman P, Foote KD,
Bowers D, Ward HE, Sanchez-Ramos J, Okun MS.
Differential and better response to deep brain stimulation of chorea compared to dystonia in
Huntington's disease. Stereotact Funct Neurosurg. 2013;91(2):129-33. doi:
10.1159/000341070. Epub 2013 Jan 22.
138. Pennington A, Sava V, Song S, Patel N, Sanchez-Ramos J (2013) Direct Actions of

Granulocyte-Colony Stimulating Factor on Human Neuronal and Monocytic Cell Lines. J
Alzheimers Dis Parkinsonism 3: 121. doi:10.4172/2161-0460.1000121
139. Song S, Wang X, Sava V, Weeber E, Sanchez-Ramos J. In vivo administration of G-

CSF restores long term depression (LTD) in hippocampal slices prepared from transgenic
APP/PS1 mice. J Neurosci Res 92:975–980 (2014)
140. Acosta, Sandra A., Tajiri, Naoki, Shinozuka, Kazutaka, Ishikawa, Hiroto, Sanberg, Paul
R., Sanchez-Ramos, Juan, Song, Shijie, Kaneko, Yuji and Borlongan, Cesar V. Combination
Therapy of Human Umbilical Cord Blood Cells and Granulocyte Colony Stimulating Factor
Reduces Histopathological and Motor Impairments in an Experimental Model of Chronic
Traumatic Brain Injury. PLOS 1 Vol 9 (3) pp e90953 (2014)
141. Catlow B, Sanchez-Ramos J Cannabinoids for the Treatment of Movement Disorders.

Current treatment options in neurology 17:370, 2015 (review article)
142. Kenneth E. Ugen, Xiaoyang Lin, Ge Bai, Zhanhua Liang, Jianfeng Caid, Kunyun Li,
Shijie Song, Chuanhai Cao & Juan Sanchez-Ramos. Evaluation of an alpha synuclein
sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson's disease.
Human Vaccines & Immunotherapeutics (2015); Human vaccines & immunotherapeutics
11:922-93, 2015
143. Sanchez-Ramos J Neurologic Complications of Psychomotor Stimulant Abuse.

International review of neurobiology 120:131-160, 2015 (review article)
144. Hergert DC, Sanchez-Ramos J, Cimino CR. 2015. Examining Huntington's disease
patient and informant concordance on frontally mediated behaviors. Journal of Clinical and
Experimental Neuropsychology 37(9):981-987.
145. Song, S , Kong, X , Acosta, SA, Sava, V , Borlongan, CV, Sanchez-Ramos, J

Promotion of Brain Self-Repair Mechanisms by Stereotaxic Microneedle Lesions Cell
Transplantation Volume: 24 Issue: 4 Pages: 773-773 , 2015
14
146. Song S, Kong X, Acosta S, Sava V, Borlongan C, Sanchez-Ramos J (2016a)

Granulocyte colony-stimulating factor promotes behavioral recovery in a mouse model of
traumatic brain injury. Journal of Neuroscience Research 94:409-423
147. Song S, Kong X, Acosta S, Sava V, Borlongan C, Sanchez-Ramos J (2016b)

Granulocyte-colony stimulating factor promotes brain repair following traumatic brain injury by
recruitment of microglia and increasing neurotrophic factor expression. Restorative neurology
and neuroscience 34:415-431
C. MULTICENTER COLLABORATIVE CLINICAL STUDIES IN REFEREED JOURNALS
148. Parkinson Study Group (and Sanchez-Ramos, J.) DATATOP: A multicenter controlled
clinical trial in early Parkinson's Disease. Arch Neurol 46:1052-1060, 1989
149. Shoulson I, and the Parkinson Study Group (with Sanchez- Ramos, J). Deprenyl and
tocopherol antioxidative therapy of Parkinsonism (DATATOP). Acta Neurol Scandinavica
(Suppl 126):80:171-175, 1989
150. Parkinson Study Group (and Sanchez-Ramos, J.) Effect of deprenyl on the progression
of disability in early Parkinson's Disease. N Eng J Med 321:1364-71, 1989
151. Jankovic J and the Parkinson Study Group (J. Sanchez- Ramos) Variable expression
of Parkinson's disease: A base-line analysis of the DATATOP cohort. Neurology,
40:1529-1534,1990
152. LeWitt P and the Parkinson Study Group (with J. Sanchez-Ramos) Deprenyl's effect at
slowing progression of parkinsonian disability: The DATATOP Study. Acta Neurol Scand 84:
suppl 136:70-86, 1991
153. LeWitt P and the Parkinson Study Group (with J. Sanchez-Ramos). Markers of
dopamine metabolism in Parkinson's disease. Neurology 42:2111-2117, 1992
154. Parkinson Study Group (and Sanchez-Ramos J) Effects of tocopherol and deprenyl on
the progression of disability in early Parkinson's disease. NEJM 328:176-183, 1993
155. Parkinson Study Group (and Sanchez-Ramos, J.). A controlled trial of lazabemide
(RO19-6327) in levodopa-treated Parkinson's Disease. Arch Neurology 51, 342-346, 1994
156. Kieburtz, Parkinson Study Group (and Sanchez-Ramos, J.). Effect of deprenyl and
tocopherol on cognitive performance in early untreated Parkinson's Disease. Neurology
44:1756-1759, 1994
157. Parkinson Study Group (and Sanchez-Ramos, J.) Cerebrospinal fluid homovanillic acid
in the DATATOP study on Parkinson's Disease. Arch Neurol 52:237-245. 1995
15
158. Impact of deprenyl and tocopherol treatment on Parkinson’s Disease in DATATOP

subjects not requiring levodopa. Ann Neurology 39:29-36, 1996
159. Parkinson Study Group (and Sanchez-Ramos, J. ). Impact of deprenyl and tocopherol
treatment on Parkinson’s Disease in DATATOP patients requiring levodopa. Ann Neurology
39:37-45, 1996
160. Huntington Study Group (and Sanchez-Ramos, J.) Unified Huntington’s disease rating
scale: reliability and consistency. Movement Disorders 11(2):136-142, 1996
161. Ropinirole Study Group (and Sanchez-Ramos, J) Ropinirole for the treatment of early
Parkinson’s Disease. Neurology 49(2):393-9, 1997
162. Marder K. et al (and the Huntington Study Group, includes Sanchez-Ramos J) Rate of
functional decline in Huntington’s Disease. Neurology 54:452-458, 2000
163. Nichols, W. C., and the Parkinson Study Group (including J. Sanchez-Ramos) Linkage
stratification and mutation analysis at the parkin locus identifies mutation positive Parkinson's
disease families [1]. Journal of Medical Genetics 39, 489-492, 2002
164. Pankratz, N. and the Parkinson Study Group (including J. Sanchez-Ramos). Genome
screen to identify susceptibility genes for Parkinson disease in a sample without parkin
mutations. American Journal of Human Genetics 71, 124-135., 2002
165. Pankratz, N., and the Parkinson Study Group (with J. Sanchez-Ramos) Significant
linkage of Parkinson disease to chromosome 2q36-37. American Journal of Human Genetics
72, 1053-1057., 2003
166. Foroud, T., and the Parkinson Study Group (with J. Sanchez-Ramos) Heterozygosity
for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology 60, 796-
801, 2003
167. Hogarth, P. et al. (and the Huntington Study Group, includes Sanchez-Ramos J)
Interrater Agreement in the Assessment of Motor Manifestations of Huntington’s Disease.
Movement Disorders 20: 293-297, 2005
168. Shoulson I, Kieburtz K, Oakes D, et al, includes Sanchez-Ramos, J) At risk for

Huntington disease - The PHAROS (Prospective Huntington At Risk Observational Study)
cohort enrolled. Archives of Neurology 2006;63(7):991-998.
169. Marshall FJ, Walker F, Frank S, et al (Includes Sanchez-Ramos, J). Tetrabenazine as

antichorea therapy in Huntington disease - A randomized controlled trial. Neurology
2006;66(3):366-372.
170. Nicholes, WC, Marek, D.K., Pauciulo, M.W., Pankratz, N., Halter, C.A., Rudolph, A.,
Shults, C.W., (includes Sanchez-Ramos, J), Julian-Baros, E.(Parkinson Study Group)
16
R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation Movement

Disorders (2007) 22 (2), pp. 254-257
171. Langbehn, D.R., Paulsen, J.S., Hedges, P., McCusker, E., Pearce, S., Trent, R.,
Abwender, D., (includes Sanchez-Ramos, J), Oakes, D. (Huntington Study Group) Predictors
of diagnosis in Huntington disease Neurology (2007) 68 (20), pp. 1710-1717
172. Dorsey ER, Beck CA, Adams M, Chadwick G, de Blieck EA, McCallum C, Briner L,
Deuel L, Clarke A, Stewart R, Shoulson I; Huntington Study Group TREND-HD Investigators
(includes J. Sanchez-Ramos) Communicating clinical trial results to research participants
Arch Neurol. 2008 Dec;65(12):1590-5.
173. Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the

TREND-HD study Huntington Study Group TREND-HD Investigators (includes J. Sanchez-
Ramos). Arch Neurol. 2008 Dec;65(12):1582-9.
174. Genomewide association study for susceptibility genes contributing to familial Parkinson
disease Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, Pugh EW, Doheny
KF, Gusella JF, Nichols WC, Foroud T, Myers RH; PSG-PROGENI (includes J. Sanchez-
Ramos) and GenePD Investigators, Coordinators and Molecular Genetic Laboratories.Hum
Genet. 2009 Jan;124(6):593-605. Epub 2008 Nov 6
175. Wheelock DV, Tempkin T, Sanchez-Ramos J. Randomized Controlled Trial of Ethyl-

Eicosapentaenoic Acid in Huntington Disease: The TREND-HD Study 65: 1582; 2008.
Archives of Neurology 2009:305-305
176. Frank S and the Huntington Study Group/Tetra-HD Investigators.(includes J. Sanchez-

Ramos) Tetrabenazine as Anti-Chorea Therapy in Huntington Disease: An Open-Label
Continuation Study. BMC Neurology 2009;9:62.
177.
178. Huntington Study Group (Kieburtz et al including J. Sanchez-Ramos) A randomized,
placebo-controlled trial of latrepirdine in Huntington disease Arch Neurol 2010; 67(2): 154-16
179. HART Investigators of the HSG (McGarry A: corresponding author; Kieburtz K:

presenting author). A Randomized, Double-Blind Placebo-Controlled Trial of ACR16 in
Huntington’s Disease. Neurotherapeutics 2011; 8(1): 135.
180. HORIZON Investigators of the Huntington Study Group and European Huntington’s
Disease Network (Kieburtz K, presenting author). Randomized, Double-Blind, Placebo-
Controlled Study of Dimebon in Individuals with Mild-to-Moderate Huntington disease.
Neurotherapeutics 2012; 9(1): 239.
181. Nichols P, Darwin K, Brocht A, Dorsey ER, Beck C, Biglan K, and Shoulson I, on behalf
of the Huntington Study Group COHORT Investigators. Safety of tetrabenazine in a
longitudinal cohort study of individuals with Huntington disease. Neurotherapeutics 2013;
10(1): 172-3.
17
182. Darwin K, Nichols P, Brocht A, Dorsey ER, Beck C, Biglan K, and Shoulson I, on behalf
of the Huntington Study Group COHORT Investigators. Treatment of chorea in Huntington
disease. Neurotherapeutics 2013; 10(1): 173.
183. Dorsey ER, Beck CA, Darwin K, Nichols P, Brocht AF, Biglan KM, Shoulson I; Natural
History of Huntington’s Disease. Huntington Study Group COHORT InvestigatorJAMA Neurol.
2013 Dec;70(12):1520-30. doi: 10.1001/ JAMA Neurol.2013.4408.
184. Goh A, Loi S, Antonopoulos S, Chiu E, and the HSG COHORT investigators and
coordinators. Characterisation of a large group of individuals with Huntington’s disease and
their relatives enrolled in the COHORT study—a longitudinal analysis of data.
Neurotherapeutics 2013; 10(1): 174-5. \
185. Cudkowicz M, McDermott M, Kieburtz K, McGarry A, de Blieck E, and the 2CARE

Investigators and Coordinators of the Huntington Study Group. Recruitment and retention
challenges in 2CARE, a long-term therapeutic clinical trial of coenzyme Q10 in Huntington’s
disease. Neurotherapeutics 2013; 10(1): 177-8.
186. Huntington Study Group HART Investigators (with J. Sanchez-Ramos). A Randomized,

Double-Blind, Placebo-Controlled Trial of Pridopidine in Huntington’s Disease. Movement
Disorders 2* (10)1407-1415, 2013
187. Marder K, Gu Y, Eberly S, Tanner CM, Scarmeas N, Oakes D, Shoulson I; Huntington

Study Group PHAROS Investigators. Relationship of Mediterranean diet and caloric intake to
phenoconversion in Huntington disease. JAMA Neurol. 2013 Nov;70(11):1382-8. doi:
10.1001/jamaneurol.2013.3487.
188. Stout et al (and CAB Investigators including J. Sanchez-Ramos) HD-CAB: A cognitive

assessment battery for clinical trials in Huntington's disease. Movement Disorders 29 (10), pp
1281-1288, 2014
189. Biglan, K and Huntington Study Group (with J. Sanchez-Ramos) Clinical-Genetic

Associations in the Prospective Huntington at Risk Observational Study (PHAROS):
Implications for Clinical Trials. JAMA neurology Volume:73 Issue:1 Pages:102-10, 2016
D. PUBLISHED PROCEEDINGS OF REFEREED SYMPOSIA
190. Sanchez-Ramos, J. and Schuster, C.R. Comparison of the effects of the intravenous
and intracerebral routes of naloxone and diallylnormorphine administration in the
morphine-dependent rhesus monkey. In, Proceedings of the 10th Congress, Collegium
Internationale Neuropsychopharmacologicum. Ed. Deniker, Radouco-Thomas, Velleneuve.
Pergamon Press, Oxford, 1978
18
191. Hefti F, Sanchez-Ramos J, Michel P, Efange S, Pressman BC: Effects of strucutural

analogues of MPP+ and related compounds on dopaminergic neurons in culture. In "Progress
in Parkinson Research" eds. F Hefti, WJ Weiner, Plenum Press, N.Y. 1989:137-144
192. Sanchez-Ramos J, Hefti F, Hollinden GE, Sick T, Rosenthal M: Mechanisms of MPP+

neurotoxicity: oxyradical and mitochondrial inhibition hypotheses. In "Progress in Parkinson
Research" eds. F Hefti, WJ Weiner, Plenum Press, N.Y. 1989:145-152
193. Factor, S.A., Sanchez-Ramos, J., Weiner, W.J. Vitamin E Therapy in Parkinson's
Disease. In, Advances in Neurology, Vol 53: Parkinson's Disease: Anatomy, Pathology and
Therapy, Eds. AD Korczyn, E Melamed, MBH Youdim, Raven Press, NY, 1990, pp 457-461
194. Levin, B.E., Llabre, M.M., Ansley, J., Weiner, W.J., Sanchez-Ramos, J., Do
Parkinsonians Exhibit Visuospatial Deficits? In, Advances in Neurology, Vol 53: Parkinson's
Disease: Anatomy, Pathology and Therapy, Eds. AD Korczyn, E Melamed, MBH Youdim,
Raven Press, NY 1990, pp 457-461
195. Martin F, Sanchez-Ramos J, Sick T, Rosenthal M. MPP+ effects on oxidative

metabolism and ion transport are spread beyond dopaminergic terminals.In, "Proceedings of
the European Conference on Parkinson's disease and extrapyramdal disorders", Ed. A.
Agnole, John Libbey CIC, Rome, 1990
196. Mash DC, Sanchez-Ramos J, Weiner WJ. Transferrin receptor regulation in

Parkinson's disease and in MPTP treated mice. In, "Proceedings of the European Conference
on Parkinson's disease and extrapyramdal disorders", Ed. A. Agnole, John Libbey CIC, Rome,
1990
197. Sanchez-Ramos J, Weiner WJ, Watson B. Early detection of lipid peroxidation

products in dopaminergic neurons incubated with MPP +. In, "Proceedings of the European
Conference on Parkinson's disease and extrapyramdal disorders", Ed. A. Agnole, John Libbey
CIC, Rome, 1990
198. Sanchez-Ramos J, Weiner WJ, Pressman B. Platelet membrane fluidity in Parkinson's

disease. In, Progress in Parkinson Research. Ed Hefti F, and Weiner WJ. Futura Pub Co, NY,
1992, pp 39-47
199. Shoulson I and the Parkinson Study Group (with J. Sanchez-Ramos) effect of
selegiline (L-deprenyl) on the progression of disability in early Parkinson's disease: a
preliminary report, in Neuroprotective Therapy in Early Parkinson's Disease, UK Rinne, E.
Heinonen (eds.) Orion Corp, Farmos, Turku, Finland, pp. 25-32, 1991
200. Mash DC, Sanchez-Ramos J., Weiner WJ. Transferrin receptor regulation in
Parkinson's disease and MPTP-treated mice. In, "Parkinson's Disease: From Basic Research
To Treatment" eds H. Narabayashi, T. Nagatsu, N. Yanagisawa, Y. Mizuno. Raven Press, NY,
1992
19
201. Singer C, Sanchez-Ramos J, Weiner WJ. Gait abnormality in essential tremor. In, XIth
International Symposium on Posture and Gait Ed M. Woollacott and F. Horak University of
Oregon Books, 1992, pp 147-151
202. Globus M, Prado R, Sanchez-Ramos J, Dietrich D, Ginsberg M, Busto R. Role of nitric

oxide in excitotoxic and ischemic damage . In: Moskowitz NA (ed). Proceedings of the 19th
Princeton Conference on Cerebrovascular Disease, 1994
203. Sanchez-Ramos J.Radicales libres y enfermedades neurodegenerativas.

Anitoxidantes y Calidad de Vida, Buenos Aires, Argentina , 2(7):14, 1995
204. Sanchez-Ramos J. Estado Actual de la Hipotesis de Los Oxiradicales en la

Enfermedad de Parkinson. Antioxidantes and calidad de Vida, Buenos Aires, Argentina,
3(9):16-21, 1996
205. Manyam B and Sanchez-Ramos J. Traditional Therapies of Parkinson’s disease.

(edited G. Stern) In, Parkinsons’ Disease, Advances in Neurology Volume 80:565-571, 1999
206. Song S, Cardozo-Pelaez F, and Sanchez-Ramos, J. Relationship of Organochlorine

Pesticides to Parkinsonism, In, Neurotoxic Factors in Parkinson’s Disease and Related
Disorders. Edited by Collins and Storch, Kluwer Academic/Plenum pp 237-246, 2001
E. NON-REFEREED ARTICLES:
207. Sanchez-Ramos, J.. Parkinson's Disease Update. Neurology Update, Continuing

Medical Education, Corp. Princeton Vol 8:2-7, 1989
208. Sanchez-Ramos, J.. Neurological Aspects of Cocaine Abuse. Psychiatry Times, March
1989
209. Earnest, M. P., Norris, J. M., Eberhardt, M. S., Sands, G. H., Adams, D., Brust, J. C.,
Garver, C. M., Helgason, C. M., Marotta, J. T., Messing, R. O., Rowland, L. P.,
SanchezRamos, J. R., Sands, G., Snodgrass, S. R., Ziegler, D. K., Whisnant, J. P.,
Rosenberg, R., Viste, K., Cohen, J. A., and Hames, R. P. 1996. Report of the AAN Task Force
on access to health care: The effect of no personal health insurance on health care for people
with neurologic disorders. Neurology 46: 1471-1480.
F. ABSTRACTS, LETTERS and BOOK REVIEWS
1. Sanchez-Ramos, J. Weiner WJ, and Hefti F. Effects of MPTP and MPP+ on

dopamine neurons in cultures of dissociated rat mesencephalon cells. Presented at the
38th Annual Meeting of American Academy of Neurology, New Orleans, Louisiana, April,
1986 Neurology 36 (suppl 1), 96
2. Sanchez-Ramos, J., Barrett, J.N., Weiner, W.J., Heikkila, R.E., and Hefti, F.
20
(1986) Selective toxicity of MPP+ for dopaminergic neurons in cultures of dissociated rat
mesencephalic cells. Society for Neurosciences. Abstract 28.13, p 91
3. Sanchez-Ramos, J., Weiner, W.J., Heikkila, R.E., and Hefti, F. (1986) Effects of
a series of structural analogues of MPTP on dopamine neurons in cultures of dissociated
cells from rat embryo mesencephalon Annals of Neurology (Abstract) 20:121.
4. Weiner, W.J., Sanchez-Ramos, J., and Hefti, F. (1986) Temporary levodopa

withdrawal. Letter to the editor, NEJM 314: 852.
5. Factor SA, Sanchez-Ramos J, Hefti F, Weiner WJ. Trauma and Parkinson's

Disease.(1987) Neurology 37 (Suppl1) 265
6. Shoulson I, and the Parkinson Study Group (which includes Sanchez-Ramos, J

among 30 co-investigators) Correlates of clinical decline in early Parkinson's disease.
Neurology (abstract)37 (suppl 1):278,1987
7. Sanchez-Ramos, J., Hollinden, G., Hefti, F., Weiner, W.J., Sick, T., and
Rosenthal, M.(1987) MPP+ inhibits mitochondrial electron transport in rat striatal slices.
Neurology 37(suppl1)340
8. Factor, S.A., Sanchez-Ramos, J., and Weiner, W.J.(1987) Parkinson's disease:

An open label study of pergolide in 63 patients failing bromocriptine therapy. Neurology
37(Suppl1)271
9. Sanchez-Ramos, J., F. Hefti, and W. J. Weiner.(1987) Paraquat and Parkinson's

Disease. Neurology (letter) 37:728
10. Michel, P.P., Sanchez-Ramos, J.., Pressman, B., Efange, S. and Hefti, F (1987)
Toxicty of Compounds related to MPP+ For Dopaminergic Neurons in Culture,
Neurosciences (Abstract) 13:72
11. Factor SA, Sanchez-Ramos J, Weiner WJ. (1987) Adrenal Medullary Autografts
in Parkinson's disease. NEJM (letter) 317;1091
12. Hollinden GE, Sanchez-Ramos J, Sick TJ, Rosenthal M.(1987) MPP+ increases
extracellular potassium in rat striatal slices: preliminary evidence that consequences of
MPP+ neurotoxicity are spread beyond dopaminergic terminals. Neurosciences (Abstract)
13:1502
13. Weiner WJ, Sanchez-Ramos J, Factor SA, Hefti F. (1987) The Efficacy of
4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease. Neurology
37(suppl1)276
14. Weiner WJ, Factor SA, Sanchez-Ramos J (1988): A comparison of
21
bromocriptine and levodopa/carbidopa alone and in combination in de novo patients with

Parkinson's disease. Abstract from International Symposium on Early Dopamine Agonist
Therapy of Parkinson's disease. Arch. Neurol. 45:207
15. Factor SA, Sanchez-Ramos J, Ingenito A, Weiner WJ. (1988) Efficacy of CR4
Sinemet in a Subgroup of Patients with Parkinson's Disease Neurology 38(suppl1) 204
16. Weiner WJ, Sanchez-Ramos J, Factor SA, Singer C. Ingenito A. (1988) Sinemet
CR and standard Sinemet: a double blind comparison in Parkinson's disease. Annals of
Neurology, 24, 180
17. Shoulson I, and the Parkinson Study Group (with Sanchez- Ramos, J).
Antioxidative experimental strategies for Parkinson's diseaes (abstract). 9th International
Symposium on Parkinson's Disease, Jersualem, Israel, June 5 -9, p19, 1988
18. Kurlan R. Clark S, Shoulson I, Penny J. (and the Parkinson Study Group with J.
Sanchez-Ramos) (1988) Economic impact of protective therapy for early Parkinson's
disease. Annals of Neurology, 24:153
19. Factor SA, MacAlarney T, Sanchez-Ramos J, Weiner WJ (1988). The effect of

sleep on motor symptomatology in Parkinson's Disease. Neurology (suppl1)260
20. Factor SA, Sanchez-Ramos J, Weiner WJ. (1988) Vitamin E Therapy in

Parkinson's Disease. Neurology 38 (suppl1)331
21. Penney J, Young AB, Shoulson I, Starosta-Rubinstein S, Snodgrass SR,

Ramos-Arroyo M, Gomez F, Sanchez-Ramos J, DeQuiroz I, Marsol N, Moreno H, Bonilla
E, Penchaszadeh G, Wexler NS.(1988) Huntington's Disease in Venezuela: 7 years of
follow-up on at-risk and symptomatic individuals. Neurology 38 (suppl1) 358
22. Factor, S.A., Sanchez-Ramos, J, Weiner, W.J. (1988) Cocaine-induced

exacerbation of Tourette's Syndrome. Ann Neurol.(letter)23:423-424
23. Shoulson I and the Parkinson Study Group (with Sanchez- Ramos, J)
Antioxidative experimental strategies aimed at slowing down the progression of Parkinson's
disease (abstract). Proceedings of the International Symposium on Alzheimer's Disease
June 12-15, 1988, Kuopio, Finland(World Federation of Neurology Research Group on
Dementia) Publications of the University of Kuopio (ISBN 951-780-488-1), pp 35-36, 1988
24. Sanchez-Ramos, J., Michel, P, and Hefti, F. Effects of MPP+ and Several
Structural Analogs on Dopamine Neurons in Culture. Symposium on Degeneration and
Regeneration Processes, Sardinia, Sept., 1988, p 57
25. Michel PP, Zawadcka H, Goldstein M, Sanchez-Ramos J, Strauss WL and Hefti

F. (1988) Characterization of MPP+ toxicity for rat dopaminergic neurons in culture. Proc.
Soc. Neurosci. 14: 491.4
22
26. Sanchez-Ramos, J, Michel, PP, and Hefti, F. (1989) The acute effects of MPP +
on the morphology of dopaminergic neurons in culture. Neurology 39 (suppl 1) 323
27. Singer, C, Sanchez-Ramos, J, Weiner, WJ, and Ackerman, M. (1989) Sexual

dysfunction in Parkinsonian men. Neurology 39 (suppl 1) 145
28. Singer, C, Sanchez-Ramos, J, Weiner, WJ. (1989) Autonomic dysfunction in PD

patients. Neurology 39 (suppl 1) 142
29. Weiner, W.J., Singer, C, Sanchez-Ramos, J.. and Sheldon, C. (1989)

Naxagolide (PHNO) in the treatment of early Parkinson's disease. ANA, New Orleans p11
30. Factor, S. A., Weiner, W. J., Sanchez-Ramos, J., Singer, C., and Ingenito, A.
(1989) Effect of increased clinical evaluations on motor response in Parkinson's disease.
ANA, New Orleans, p.11
31. Factor, S. A., Sanchez-Ramos, J., and Weiner, W. J. (1989) Trauma as an

Etiology of Parkinsonism: Opinions in the Nineteenth Century. (letter) Movement Disorders
4: 284-285
32. Sheremata, W.A., Bohn, N., Berger, J. Tourtelotte, W., Sanchez-Ramos, J.,
Weiner, W. J. (1989) Increased serum and lowered cerebrospinal gamma inteferon (IFN-g)
in Parkinson's disease. Society for Experimental Neuropathology, New Orleans
33. Hefti F, Michel PP, Dandapani, B.K., Knusel, B., Sanchez- Ramos, J., Efange,
S. (1989) Toxic effects of potential environmental toxins related to MPP+ on rat
dopaminergic neurons in culture. Society for Neuroscience 15:137
34. Pablo, J., Basile, M., Efange, S. M., Sanchez-Ramos, J., Weiner, W. J., and
Mash, D. C. (1989) Quantitative in Vitro Autoradiography of Transferrin Receptors in the
Striatum of MPTP Treated Mice. Soc. for Neurosci.15, 346
35. Terry, L. M., Keran, E., Hearn, L., Sanchez-Ramos, J., Pablo, J., Basile, M., and
D. C. Mash., (1989) Chronic Cocaine- Induced Alterations in Dopaminergic Pre- and
Postsynaptic Markers. Soc.for Neurosci., 15: 803
36. Sanchez-Ramos, J., Weiner, W.J., and Watson, B.(1989) Early detection of lipid
peroxidation in cultures of dopamine neurons treated with MPP+. Symposium on the
Etiology, Pathophysiology and Treatment of Parkinson's Disease, ANA, New Orleans
37. Shoulson I and the Parkinson Study Group (and Sanchez-Ramos J). Deprenyl
in early Parkinson's disease: symptomatic versus protective efficacy (abstract) Neurology
(Suppl 1)40:153, 1990
38. Oakes D and the Parkinson Study Group (and Sanchez-Ramos J). Progression
23
of early Parkinson's disease until levodopa therapy is required (abstract) Neurology (suppl
1)40:378, 1990
39. Jankovic J, McDermott, Carter J, Gautheier S, (and the Parkinson Study Group
with J. Sanchez-Ramos) Variable clinical expression of Parkinson's disease: Analysis of
the DATATOP database. Neurology 40(supp1)168, 1990
40. Singer C, Weiner WJ, Sanchez-Ramos J. (1990) Sexual dysfunction in early

Parkinson's disease. Neurology 40 (Suppl1) 221
41. Sanchez-Ramos J, Martin F, Sick TJ, Rosenthal M., (1990) MPP+ selectively
decreases oxygen consumption in rat striatal slices. Neurology 40 (Suppl 1) 444
42. Shoulson I., and the Parkinson Study Group (and Sanchez- Ramos J) Deprenyl
in early Parkinson's disease: symptomatic vs protective efficacy? Neurology 40(suppl1) 153
43. Oakes D and the Parkinson Study Group (Sanchez-Ramos, J). Progression of
early Parkinson's disease until levodopa therapy is required. Neurology 40(suppl 1):370,
1990
44. Martin F, Sanchez-Ramos J, Sick T, Rosenthal M. MPP+ effects on oxidative

metabolism and ion transport are spread beyond dopaminergic terminals.In, "Proceedings
of the European Conference on Parkinson's disease and extrapyramdal disorders", Ed. A.
Agnoli, Abstract book, John Libbey CIC, Rome, p 49, 1990
45. Mash DC, Sanchez-Ramos J, Weiner WJ. Transferrin receptor regulation in

Parkinson's disease and in MPTP treated mice. In, "Proceedings of the European
Conference on Parkinson's disease and extrapyramdal disorders", Ed. A. Agnoli, Abstract
book, Libbey CIC, Rome, p 48, 1990
46. Sanchez-Ramos J, Weiner WJ, Watson B. Early detection of lipid peroxidation

products in dopaminergic neurons incubated with MPP +. In, "Proceedings of the European
Conference on Parkinson's disease and extrapyramdal disorders", Ed. A. Agnoli, Abstract
book, John Libbey CIC, Rome, p 54, 1990
47. Weiner WJ, Sanchez-Ramos J, Singer C. Driving and Parkinson's disease.In,

"Proceedings of the European Conference on Parkinson's disease and extrapyramdal
disorders", Ed. A. Agnoli, Abstract book, John Libbey CIC, Rome, p 90, 1990
48. Singer C, Sanchez-Ramos J, Weiner WJ. Hydroxytryptophan is not useful in

cerebellar syndromes. Ann Neurol 28:300, 1990
49. Singer C, Sanchez-Ramos J, Rey G, Lewin B, Weiner WJ. Acquired immune

deficiency syndrome dementia complex presenting as an unusual unilateral hand tremor,
clumsiness and posturing.Ann Neurol 28:301, 1990
24
50. Pelusio R and the Parkinson Study Group (and J. Sanchez- Ramos) DATATOP:
Managing an accelerated trial (abstract) Controlled Clincial Trials 11:304, 1990
51. Oakes D and the Parkinson Study Group (and Sanchez-Ramos J) Investigator
effects in a multicenter trial for Parkinson's disease. (abstract) Controlled Clincial Trials,
11:284,1990
52. Hall WJ and the Parkinson Study Group (and Sanchez-Ramos J.) Statistical
issues in monitoring a 2X2 factorial clinical trial (abstract) Controlled Clinical Trials
11:2264,1990
53. Environmental Influences Working Group of the Parkinson Study Group (and J.
Sanchez-Ramos) Smoking and the age of onset of Parkinson's disease: Analysis of the
DATATOP Cohort (abstract) Annals of Neurology, 1990
54. Kieburtz K, and the Parkinson Study Group (and J. Sanchez-Ramos)

Neuropsychological evaluation in early untreated Parkinson's disease (abstract) Annals of
Neurology, 28:236,1990
55. Weiner WJ, Sanchez-Ramos J, and Singer C. Driving and Parkinson's diseae.
In, "Proceedings of the European Conference on Parkinson's disease and extrapyramdal
disorders", Ed. A. Agnoli, Abstract book, John Libbey CIC, Rome, 1990
56. Sheremata WA, Tourtelotte W, Sazant A, Levine CS, Sanchez- Ramos J, Weiner
WJ. Increased serum and cerebrospinal fluid interferon-gamma in early untreated
Parkinson's disease. Ann Neurol 28:296, 1990
57. Sanchez-Ramos J, Reynoso L, Singer C, Weiner WJ, Pressman B. Alterations

in platelet membrane fluidity. Neurology (Abstract) 41(suppl 1)p153, 1991
58. Factor S, Weiner WJ, Sanchez-Ramos J, Singer C, Sheldon C, Cornelius L.

Double-blind comparison of bromocriptine and levodopa/carbidopa both alone and in
combination in de novo Parkinson patients. Neurology (Abs) Suppl 1, p172, 1991
59. Sanchez-Ramos J. Banisterine and Parkinson's disease. Neurology

(Abstract)suppl 1,p305, 1991
60. Weiner WJ, Singer C, Sanchez-Ramos J. Gait abnormality in essential tremor.

Neurology (Abstract) suppl 1, p326, 1991
61. Parkinson Study Group (Sanchez-Ramos J.) DATATOP and clinical

neuromythology IX. Neurology 41:771-777, 1991
62. Mash DC, Pablo J, Buck BE, Sanchez-Ramos J, Weiner WJ. Distribution and
number of transferrin receptors in Parkinson's disease and in MPTP-treated mice.(abstract)
Movement Disorder 6:271, 1991
25
63. Singer C, Berger J, Weiner WJ, Sanchez-Ramos J. Movement disorders in

acquired immunodeficiency syndrome. Movement Disorders (Abs) 6:275, 1991
64. Singer C, Weiner WJ, Sanchez-Ramos J, Ackerman M. Sexual function in

patients with Parkinson's disease. J Neurol Neurosurg Psychiat 54(10):942, 1991
65. LeWitt P, Galloway M, Oakes D, Watts A, Mattson W and the Parkinson Study
Group (with J. Sanchez-Ramos) Homovanillic acid, other monoamine metabolites, and
xanthine in parkinsonian CSF. (abstract) Neurology 41: (suppl1) 379, 1991
66. Song S, Ortoll R, Mash D, Weiner WJ, Sanchez-Ramos, J.Acute effects of

MPP+ on ATP production in mesencephalic cultures of dopaminergic neurons: protection
by 21-aminosteroids. (Abstract) Neurology 42: supplement 3, 379, 1992
67. Sanchez-Ramos J., Song S, Weiner WJ, Busto R. Potential cytotoxicity of

norcocaine for developing dopaminergic neurons. (Abstract) Neurology 42:supplement 3,
406, 1992
68. Weiner WJ, Singer C, Sanchez-Ramos J., Goldenberg J. Use of

levodopa/carbidopa in Parkinson patients with a history of melanoma. (Abstract) Neurology
42: supplement 3, 419, 1992
69. LeWitt P, Galloway M, Matson W, Milbury P, McDermott, M, Oakes D, and the

Parkinson Study Group (with Sanchez-Ramos, J.) Markers of endogenous dopamine
synthesis in Parkinson's disease. (Abstract) Neurology supplement 3, 420, 1992
70. Bowen BC, Sanchez-Ramos J, Lampman D, Tyson L, Block RE. In vivo Proton
spectroscopy of the midbrain and putamen of Parkinson's disease patients.Soc Mag Res
Med (Abs), 1992
71. Sanchez-Ramos J, Basit A, Song S, Roberts, Jr, EL. Inhibition of mitochondrial

electron transport results in earlier peaks of superoxide release from sub-mitochondrial
particles in aged rats. GSA meeting, 1993
72. Sanchez-Ramos J, Overvik E, Ames B. A marker of oxyradical-mediated DNA-

damage is increased in striatum of Parkinson's disease brain. Neurodegeneration
3(3):197-204, 1994
73. Sanchez-Ramos J, Ortoll R, Singer C, Shulman L, Weiner WJ, Paulson G.

Visual hallucinations in Parkinson's disease. Ann Neurol [Abs] 34:264, 1993
74. Factor, SA, Weiner WJ, Sanchez-Ramos J, Singer C, Shulman L, Brown D,

Sheldon C. Use of pramipexole a novel DA agonist in advanced Parkinsons' Disease. New
Trends in Clinical Neuropharmacology Vol VII, n.3/93 (1993)
26
75. Singer C, Parra A, Sanchez-Ramos J, Shulman LM, Weiner WJ. Subjective

unsteadiness and tandem gait in early Parkinson's Disease. Neurology 44 (suppl 2) A246,
1994
76. Shulman L, Singer C, Sanchez-Ramos J, Weiner WJ. Internal tremor in patients

with Parkinson's Disease. Abstract XVth World Congress of Neurology, 1993
77. Singer C, Shulman L, Sanchez-Ramos J, Weiner WJ. Subjective unsteadiness

in Parkinson's Disease. Abstract XVth World Congress of Neurology, 1993
78. Sanchez-Ramos J, Song S. Facca A, Basit A, Epstein CJ. Development and

degeneration of dopamine neurons in primary mesencephalic cultures prepared from SOD1
transgenic mice. Movement Disorders (Abstract),9:478, 1994
79. Sanchez-Ramos J, Song S, Facca A, Basit A, Globus M. Nitric oxide mediates

glutamate toxicity for GABAergic neurons in rat primary striatal cell cultures. 3rd
International Congress of Movement Disorders. Movement Disorders 9(suppl 1):108, 1994
(Abstract), 1994
80. Hearn L, Sambol N, Pablo J, Hime G, Doepel F, Sanchez-Ramos J, Mash D.

Some preliminary observations on the pharmacokinetics and disposition of ibogaine Amer
Acad Forensic Sci, (Abs for 1995 meeting)
81. Douyon R, Levin B, Raymon L, Hearn WL, Sanchez-Ramos, J, Mash DC.

Neuropsychiatric effects of ibogaine in drug dependent patients. NCDEU Annual Meeting,
June, 1995
82. Mash DC, Douyon R, Hearn WL, Sambol NC, Sanchez-Ramos J. Preliminary
report on the safety and pharmacokinetics of ibogaine. Soc Biol Psychiat Annual Meeting,
1995
83. Huntington Study Group (and Sanchez-Ramos, J) Internal validity and

consistency of the Unified Huntington's Disease Rating Scale. Neurology (suppl)
45:334P,1995
84. Sanchez-Ramos J, Song S, Facca A, Basit A. Dieldrin and DA Neuron Toxicity.

Neurology (suppl) 45:A379, 1995
85. Staley JK, Rothman RB, Rice KC, Sanchez-Ramos J, Weiner WJ, Mash D.
Mapping the distribution of Kappa-2 opioid receptors in Parkinson’s disease: a ligand
binding and autoradiography study. Neurology (suppl) 46:A443, 1996
86. Sanchez-Ramos J, Kovera C, Raymon L, Mash D. Quantitative assessment of

tremor and involuntary movements during cocaine abstinence. Committee on Problems of
Drug Dependence. June, 1996
27
87. Sanchez-Ramos J, Kovera C, Mash D. Sub-clinical parkinsonism associated

with cocaine abstinence. Movement Disorders. 11:600, 1996
88. Sanchez-Ramos J, Mann J, Song S, Bean J, Fleming L. Plasma levels of

organochlorine pesticides, neurotoxicity and Parkinson’s disease. XIIth International
Symposium on Parkinson’s disease, London, March 1997
89. Sharma K, Romano J, Facca A, Sanchez-Ramos, J. Sympathetic skin response

and the heart rate variability in patients with Huntington’s disease. Neurology 48(3):A121,
1997
90. Song S and Sanchez-Ramos J. Differentiation of mouse embryonic stem cells

into dopaminergic neurons in vitro. Symposium on Etiology, Pathogenesis and Treatment of
Parkinson’s Disease. Abs in Movement Disorders 12 (5):833,1997
91. Cardozo-Pelaez F, Song S, Parthasarathy A, Naidu K, Epstein CJ, Sanchez-

Ramos J. Age-Dependent Increase in Oxidative DNA Damage in Nigrostriatal System is
Attenuated in Transgenic h-SOD Mice. Neurosci. Abst. 23:350, 1997
92. Sanchez-Ramos J, Song S, Parthasarathy A, Naidu K, Cardozo-Pelaez F,

Epstein CJ. Indices of oxidant stress change with age in the nigrostriatal system. Ann
Neurol 42:457, 1997
93. Cardozo-Pelaez F, Song S, Hazzi C, Parthasarathy A, Sanchez-Ramos J.

Accumulation of oxidatively-induced DNA damage, but not protein carbonyl content in
mouse nigro-striatal system during aging. Neuroscience Abs. Vol 24:1494, 1998
94. Song S, Hazzi C, Parthasarathy A, Cardozo-Pelaez F, Sanchez-Ramos, J Can

mouse embryonic stem cells be used as a source of dopaminergic neurons?
EXPERIMENTAL NEUROLOGY 153 (2): 381-381 OCT 1998
95. Sanchez-Ramos J. Cardozo-Pelaez F, Song S. Differentiation of neuron-like

cells from Bone Marrow Stromal Cells. Movement Disorders, 12(s2):122, 1998
96. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Willing A, Saporta S,

Sanberg P. Bone marrow stromal cells grafted into adult rat brain migrate, organize in
architectonic patterns and express neuronal markers. Neurology 52 (suppl2), 1999
97. Wendell CM, Hauser RA, Nagaria MH, Sanchez-Ramos J, Zesiewicz, T.A. Chief
complaints of patients with Parkinson's disease. Neurology 52 supp2, 1999
98. Cardozo-Pelaez F, Brooks PJ, Stedeford T, Song S, and Sanchez-Ramos J. 8-

hydroxy-deoxyguanosine and ethenoadenosine are differentially repaired in cerebellum and
cortex of mouse brain. Society for Neuroscience Abs. Vol 25, 1318, 1999
99. Hazzi C, Sanchez-Ramos J, Cooper D.R. Protein kinase C-beta regulation in
28
NGF-induced differentiation of PC12 cells. Society for Neuroscience Abs. Vol 25, 1383,
1999
100. Sanchez-Ramos J, Book Review on “Advances in Research on

Neurodegeneration” vol 6 (special edition of J Neural Transm 1999; supl 55) Poewe W,
Ransmayr G., eds. Wien, New York: Springer-Verglag, 1999, Movement Disorders 15:367,
2000
101. S. Song, Cardozo-Pelaez F, Stedeford T, Dailey M, Willing A, Saporta S, Janssen

W, Zigova T, Sanberg P, Sanchez-Ramos, J. Study of Optimal Conditions for
Differentiation of Neural Cells from Bone Marrow Precursors” Soc for Neuroscience,
312.20, p 159, 2000
102. Baker M, Gieron-Korthals M, Sanchez-Ramos J. A case of paroxysmal dystonia

associated with succinate dehydrogenase deficiency. Movement Disorders
15(5):1047,2000
103. Stedeford T, Cardozo-Pelaez F, Nemeth N, Di Carlo G, Harbison RD, and

Sanchez-Ramos J. Comparison of base-excision repair capacity in proliferating and
differentiated PC12 cells following acute challenge with dieldrin. Society for Neurosciences
Abstract 94.10, p 51, 2000.
104. Cardozo-Pelaez F, Stedeford T, Brooks PJ, Song S, Sanchez-Ramos J.

Diethylmaleate induces 8- oxoguanosine glycosylase (OGG1) levels in specific mouse
brain regions. Soc. For Neurosci Abstract 388.17, p 200, 2000
105. Kruman II, Cardozo-Pelaez F, Kumaravel TS, Stedeford TJ, Lohani A, Evans M,
Sanchez-Ramos JR, Mattson MP. Folate deficiency is neurotoxic and potentiates
oxidative stress by impairing DNA repair in models of Alzheimer's disease MOLECULAR
BIOLOGY OF THE CELL 12: 25A-25A 137 Suppl. S, NOV 2001
106. Sanchez-Ramos J, Song S, Willing A, Zigova T, Kamath S, O’Neill J, Sanberg P.

Molecular and Cellular Evidence for Neural Progenitors in Human Umbilical Cord Blood.
Neurology May, 2001
107. Sanchez-Ramos J. “The Straight Dope on Addiction to Dopamimetic Drugs”

Letter to the Editor, Movement Disorders 17:223-224, 2002
108. Sanchez-Ramos J, Song S, Kamath SR, Zigova T, Willing A, Cardozo-Pelaez F,

Stedeford T, Chopp M, Sanberg PR. “Neural Gene Expression in Human Umbilical Cord
Blood Cells” Abstract, American Society for Neural Transplanation and Repair,
NEUROLOGY 56 (8): A6-A6 Suppl. 3 APR 24 2001
109. Lixiam J, Willing AE, Milliken M, Poulos S, Sanchez-Ramos J, Zigova T, Song S,

Chen J, Chopp M, Sanberg PR. “Intravenous or intracranial transplantation of umbilical
cord mononuclear cells reduces hyperactivity in a rodent model of stroke” American
29
Society for Neural Transplantation and Repair, Abstract May 2001
110. Sanchez-Ramos J. “Psychoactive Plants” Review of book

Psychopharmacology of Plant-derived Drugs. By Marcello Spinelli MIT Press, Boston and
London in Trends in Neurosciences (2001).
111. Cardozo-Pelaez F, Stedeford T, Song S, and Sanchez-Ramos J. Increased

Oxidative Stress In An In Vitro Model Of Neuronal Differentiation. American Society for
Neural Transplantation and Repair, Abstract May 2001.
112. Stedeford T, Cardozo-Pelaez F, Song S. and Sanchez-Ramos J. Dieldrin-

Induced Changes In DNA Damage And Repair In An In Vitro Model Of Neuronal
Differentiation Abstract, American Society for Neural Transplantation and Repair, May,
2001.
113. Song S, Kamath S, Sanberg PR, Zigova T, Willing A, Goldman SA, and
Sanchez-Ramos J. Separation of cells expressing nestin and mushashi-1 from human
bone marrow and umbilical cord blood INTR-8 Abstract Exp. Neurology 175: 418, 2002
114. Newman M, Sanberg PR, Sanchez-Ramos J, Willing AE, Bickford PC, Manresa
J, and T Zigova. Optimal conditions to study the properties of human umbilical cord blood
cells exposed to neuralizing agents. INTR-8 Abstract. Exp Neurology 175: 432, 2002
115. Zigova T, Song S, Willing AE, Hudson JE, Sanberg PR and J. Sanchez-Ramos,
Developing rat brain as a tool to study properties of cells derived from hematopoietic
sources. INTR-8 abstract Exp Neurol 175: 433, 2002
116. Sanberg PR, Chopp M, Willing AE, Zigova T, Saporta S, Song S, Bickford P,
Garbuzova-Davis S, Newman M, Cameron DR, and J. Sanchez-Ramos. Potential of
umbilical cord blood cells for brain repair. Abstract S10-02 Journal of Neurochem 81 (Suppl
1), 2002
117. D.S.Chappell, T.L.Butler, M.Navidomskis, N.Patel, C.Kassed, J.Sanchez-

Ramos, D.R.Cooper, K.Pennypacker. Protein Kinase C Ii Is Up Regulated In Discreet
Neurons After Middle Cerebral Artery Occlusion. Program No. 301.13. 2002 Abstract
Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2002.
118. L.Jiang, C.J.Cassady, J.Mallery, T.Zigova, J.Sanchez-Ramos, S.Song,

P.R.Sanberg, A.E.Willing. Does Administration Of Umbilical Cord Blood Stem Cells Alter
The Inflammatory Response After Stroke?. Program No. 389.4. 2002 Abstract
Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2002.
119. M.B.Newman, T.Zigova, A.E.Willing, P.C.Bickford, S.Saporta, J.Sanchez-

Ramos, P.R.Sanberg. Migration Behavior Of Human Umbilical Cord Blood ( Hucb ) Cells To
Normal And Injured Brain.. Program No. 423.17. 2002 Abstract Viewer/Itinerary Planner.
30
Washington, DC: Society for Neuroscience, 2002.
120. J.Sanchez-Ramos, S.Song, T.Kamath, D.Mosquera, D.DeMesquita, T.Zigova.

Transdifferentiation Of Bone Marrow Stromal Cells Into Neuron - Like Cells. Program No.
618.10. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience,
2002.
121. T.S.Zigova, S.Song, A.E.Willing, J.E.Hudson, N.Chen, S.Garbuzova-Davis,

J.Sanchez-Ramos, P.R.Sanberg. Properties Of Hematopoietic - Derived Cells In
Developing Rat Brain. Program No. 525.10. 2002 Abstract Viewer/Itinerary Planner.
Washington, DC: Society for Neuroscience, 2002.
122. J.E.Hudson, N.Chen, M.S.Almeida, A.E.Willing, S.Saporta, D.W.Cahill,

J.Sanchez-Ramos, P.R.Sanberg, T.Zigova. Proliferation Of Human Umbilical Cord Blood
Cells ( Hucb ) In Mitogen - Free Conditions. Program No. 817.9. 2002 Washington, DC:
Society for Neuroscience, 2002.
123. S.Song, S.Kamath, D.L.Vesely, D.Mosquera, T.Zigova, P.Sanberg, J.Sanchez-

Ramos. Expression Of Brain Natriuretic Peptide By Human Bone Marrow Stromal Cells.
Program No. 824.3. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for
Neuroscience, 2002.
124. A.E. Willing, J. Mallery, J. Cassady, J. Sanchez-Ramos, P.R. Sanberg. G-Csf

Stimulated Peripheral Blood Mononuclear Cells As A Possible Treatment For Stroke.
American Society for Neural Transplantation and Repair (Exp Neurol 181, 2003)
125. N. Chen, S. Song, J.E. Hudson, A.E. Willing, S. Garbuzo-Davis, J. Sanchez-

Ramos, P. Sanberg, and T. Zigova. Neural And Hematopoietic Antigens In Cultured
Human Umbilical Cord Cells. American Society for Neural Transplantation and Repair (Exp
Neurol 181: 89, 2003)
126. J. E. Hudson, S. Song, N. Chen, P. Walczak, A.E. Willing, S. Saporta, S.

Garbuzova-Davis, J. Sanchez-Ramos, P. Sanberg and T. Zigova. Proliferative Capacity Of
Human Umbilical Cord Blood. American Society for Neural Transplantation and Repair
(Exp Neurol 181: 94, 2003
127. Walczak, S. Song, N. Chen, J.E. Hudson, A.E. Willing, J. Sanchez-Ramos, P.C.
Bickford, P.R. Sanberg, and T. Zigova. Can Neurogenic Subventricular Zone In Aging
Animals Influence Survival, Migration And Differentiation Of Human Umbilical Cord Blood-
Derived Progenitors. American Society for Neural Transplantation and Repair (Exp Neurol
181: 109, 2003
128. .E.Hudson; S.Song; N.Chen; P.Walczak; P.Jendelova; A.Willing; C.Phelps;

J.Sanchez-Ramos; P.Sanberg; T.Zigova Progenitor Cells From Adult Bone Marrow Exhibit
Neural Phenotypes In Culture And Migrate Within The Developing Rat Brain. Society for
Neurosciences Ab 150.18, 2003
31
129. P.Walczak; N.Chen; J.E.Hudson; A.E.Willing; S.N.Garbuzova-Davis; J. Sanchez-

Ramos; P.C.Bickford; P.R.Sanberg; T.S.Zigova . Rat Subventricular Zone As A Model To
Study Pluripotent Properties Of Human Umbilical Cord Blood Cells. Society for
Neurosciences Ab 151.13, 2003
130. N.Chen; S.Song; J.E.Hudson; P.Walczak; A.E.Willing; J.Sanchez-Ramos;

P.R.Sanberg; T.Zigova. can human umbilical cord blood progenitors expand and
sequentially differentiate toward neural lineages? Society for Neurosciences Ab 151.14,
2003
131. D.Mosquera; V.Sava; S.Song; F.Cardozo-Pelaez; J.Sanchez-Ramos. Effects Of

Melanin And Manganese On Dna Damage And Repair In Pc12 - Derived Neurons. Society
for Neurosciences Ab 669.1, 2003
132. V.Sava; D.Mosquera; S.Song; K.Calero; R.Harbison; F.Cardozo-Pelaez;

J.Sanchez-Ramos Distribution Of Oxidative Dna Damage And Oxyguanosine Glycosylase
Activities Across Brain Regions Of Mice Injected With A Single Dose Of Rubratoxin - B.
Society for Neurosciences Ab 669.4, 2003
133. Hudson, J.E., Chen, N., Song, S., Walczak, P., Sanberg, P., Sanchez-Ramos, J.,
Zigova, T. Hematopoietic and neural antigens in blood-derived progenitors. Keystone
Symposium, Stem Cells, Keystone, Co. 2004.
134. Sanchez-Ramos J, Kamath S, Walczak P, Chen N, Heller R, and Zigova T.

Switching Cell Fate with Human NeuroD1.Movement Disorders 119:Supplement 9, p S117,
2004
135. Sava V, Velasquez A, Song S, Sanchez-Ramos J The Ubiquitous Mycotoxin

Ochratoxin B Causes Dopamine Depletion and Alterations in Oxidative DNA Repair in
Striatum. Movement Disorders 19: 1120, 2004
136. V. Sava, A. Velasquez, S. Song, J. Sanchez-Ramos. Dopaminergic

Neurotoxicity Associated With Deficit In Repair Of Oxidative Dna Damage Caused By
Ochratoxin-A . Society for Neurosciences, 2004
137. S. Song, J. Cuevas and J. Sanchez-Ramos. Transdifferentiation Of Bone

Marrow Stromal Cells Into Neuron-Like Cells. Experimental neurology 187 (1): 227-227
May 2004
138. Sanchez-Ramos J, Sava V. Mycotoxins: Can low level, non-lethal exposure result
in Parkinsonism? Journal of the Neurological Sciences 2005;238:S8-S8.
139. Chen N, Kamath S, Hudson JE, et al. A comparison of floating and adherent
populations from human umbilical cord blood cells. Experimental Neurology
2005;193(1):242-242.
32
140. Sava V, Velazquez A, Song S, Sanchez-Ramos J. Regulation of DNA repair in

the MPTP mouse model of Parkinson's disease. Movement Disorders 2005;20(9):1248-
1248.
141. Sanchez-Ramos J. Mozart's movements. Movement Disorders

2006;21(9):1556-1556.
142. Sanchez-Ramos J, Reimer D, Zesiewicz TA, Sullivan K, Nausieda PA.

Quantitative tremor analysis in welders: Comparison with idiopathic Parkinson's disease
(IPD) and essential tremor (ET). Movement Disorders 2006;21(9):1548-1549
143. Sanchez-Ramos J, Song S, Kamath S. Role of NeuroD1 in the generation of

new neurons in the adult brain. Neurobiology of Aging 2006;27:S17-S18
144. Catlow, B, Sanchez-Ramos J, G. Arendash Effects of environmental enrichment

on neurogenesis in transgenic PS1/APP mice Society for Neuroscience Program # 763.11,
San Diego 2007
145. Sava V, Harbison R, Sanchez-Ramos J. Effects of diethyl maleate

preconditioning on the expression of DNA repair genes in midbrain elicited by Ochratoxin-A
(Society of Toxicology Symposium, Seattle, WA in March 2008).
146. Sullivan K, Ward C, Hauser R, Staffetti J, Sanchez-Ramos J and Zesiewicz T.

Accelerometry: Variable Correlation with functional impact of tremor. Neurology 70(11)
A290, 2008
147. Sanchez-Ramos J, Song S, Cao C, Lin X, Mori T, Arendash G. G-CSF reduces

hippocampal amyloid load and improves performance in a Tg AD Mouse Model.
International Conference on Alzheimer’s Disease (ICAD), Chicago, July 2008
148. Sanchez-Ramos J, et al., Filgrastim (G-CSF) increases Hippocampal

Neurogenesis Society for Neuroscience Nov 18, 2008,
149. Chicago Wheelock, D.V., Tempkin, T., Sanchez-Ramos, J., 2009. Randomized
Controlled Trial of Ethyl-Eicosapentaenoic Acid in Huntington Disease: The TREND-HD
Study (vol 65, pg 1582, 2008). Archives of Neurology 66, 305-305.
150. Sanchez-Ramos J, Song S, Mori T et al. Mechanisms of Action of Filgrastim in

a Mouse Model of AD Cell Transplantation 18: 2; 233, 2009
151. Sanchez-Ramos J, Mori T, Sava V, Song S Effects of G-CSF in the MPTP

Mouse Model of PD International Symposium on Movement Disorders S45, 2009
152. Butterfield, L., Oelke, L. Cimino, C., Hauser, R. & Sanchez-Ramos, J.

(Published Online by Cambridge University Press 29 Apr 2009). Apathy, depression, and
33
cognitive functioning in Parkinson’s disease. Journal of International Neuropsychological

Society, volume 15, supplement 1, p 128. doi:10.1017/S1355617709090420,
http://journals.cambridge.org/action/displayIssue?
jid=INS&decade=2000&volumeId=15&issueId=S1&iid=5514584 Poster presented at
36th Annual Meeting of the International Neuropsychological Society, Atlanta, GA. February
2009.
153. Oelke, L, Butterfield, L, Cimino, C., Sanchez-Ramos, J. & Hauser, R. (Published

Online by Cambridge University Press 29 Apr 2009). The unique effects of anxiety and
depression on cognitive functioning in Parkinson’s disease. Journal of International
Neuropsychological Society, volume 15, supplement 1, p 130.
doi:10.1017/S1355617709090420,
154. Oelke, L., Butterfield, L., Cimino, C., Sanchez-Ramos, J., McCall, M., Pugliese,
L., Ling, L, Stell, B. & Annis, J. (2008) Characterization of frontal lobe behavioral
syndromes in Huntington’s Disease (HD). Poster presented at the Second Annual
Huntington’s Disease Clinical Research Symposium, St. Petersburg, Abstract published in
Neurotherapeutics: The Journal of the American Society for Experimental
NeuroTherapeutics, 6 (1), p 211.
155. Cimino, C., Butterfield, L, Oelke, L., Balderston, C, Sanchez-Ramos, J., Hauser,
R. (Published Online by Cambridge University Press 08 Mar 2007) Rate of agreement in
ratings of apathy between PD patients and their caregivers, Journal of International
Neuropsychological Society, volume 14, supplement 1, p. 93.
doi:10.1017/S1355617707079969
156. Kieburtz, K., McDermott, M.P., Voss, T.S., Corey-Bloom, J., Deuel, L.M., Dorsey,
E.R., Factor, S., Geschwind, M.D., Hodgeman, K., Kayson, E., Noonberg, S., Pourfar, M.,
Rabinowitz, K., Ravina, B., Sanchez-Ramos, J., Seely, L., Walker, F., Feigin, A., A
Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease (2010).
Archives of Neurology 67, 492-492.
157. Johan, I., Chari, A., Gooch, C.L., Sullivan, K.L., Dempsey, L.E., Sanchez-Ramos,
J., Zesiewicz, T.A., 2010. Retrospective Analysis of the Use of Varenicline (Chantix (R)) in
Ataxia. Neurology 74, A251-A251. Stromal Cells in Cocultures of Fetal Dopaminergic
Neuronal Cultures. Cell Transplantation 20, 585-586.
158. Song, S., Song, S., Chuanhai, C., Li, K., Sava, V., Arendash, G., Sanchez-Ramos,
J., 2010. Amplification of Brain Self-Repair by Stereotaxic Microlesions. Cell
Transplantation 19, 363-364
159. Cao, C.H., Lin, X.Y., Li, W., Jianfeng, C., Kunyu, L., Shijie, S., Sanchez-Ramos, J.,
2011. Antigen-Sensitized Dendritic Cell Vaccine Against Human alpha-Synuclein: A
Potential Cell-Based Therapy Against Parkinson's Disease. Annals of Neurology 70, S14-
S14.
34
160. Sanchez-Ramos, J., Sava, V., Li, K., Song, S., (2013). Effects of bone marrow
replacement and treatment with granulocyte-colony stimulating factor (G-CSF) in TgQ140
HD mice. Neurotherapeutics 10, 174-174
161. Acosta, S. A.; Tajiri, N.; Shinozuka, K.; Ishikawa, H] ; Song, S; Sanberg, PR;
Sanchez-Ramos, J; Kaneko, Y; Borlongan, CV. Human Umbilical Cord Blood Cell
Transplantation With Adjunct Treatment of Granulocyte Colony-Stimulating Factor Reduces
Histopathological and Motor Impairments in an Experimental Model of Chronic Traumatic
Brain Injury Cell Transplantation 23(6) Pages: 762
162. Sanchez-Ramos, J.; Song, S.; Sava, V. Direct delivery of gene-silencing

molecules into brain by the olfactory route. Movement Disorders Volume: 29 Issue:14
Pages: 1845 Published: DEC 2014
163. Butterfield LC, Cimino CR, Salazar RD, Lee CS, Haley WE, Sanchez-Ramos J,
Okun MS, Bowers D. 2015. The Parkinson's active living (PAL) program: A behavioral
intervention targeting apathy in Parkinson's disease. Movement Disorders 30:S55-S55
164. Sanchez-Ramos J. 2015. The Entourage Effect of the Phyto-cannabinoids. Annals

of neurology 77(6):1083-1083.
165. Song S, Song S, Kong X, Acosta SA, Sava V, Borlongan CV, Sanchez-Ramos J.
2015. Promotion of Brain Self-Repair Mechanisms by Stereotaxic Microneedle Lesions.
Cell Transplantation 24(4):773-773
166. Sanchez-Ramos J, Song S, Sava V. 2015. Nanoparticles for Direct Nose-to-Brain

Delivery of Gene Therapy. Neurotherapeutics 12(3):681-682
167. Sanchez-Ramos J The entourage effect of the phytocannabinoids. Ann Neurol

77:1083, 2015 (letter to the editor)
168. Cimino, CR; Hergert, D; Johnson, P; Sanchez-Ramos, J Relationship Between

Affective and Cognitive Functioning in At-risk and Presymptomatic Huntington Disease
Patients. NEUROTHERAPEUTICS Volume: 13 Issue: 1 Pages: 254-254 Meeting
Abstract: 26Published: JAN 2016
Non-published abstracts (posters at meetings)
Development of Chitosan Nanoparticles for Intranasal Delivery of RNA Interference to the

Brain Stephen Aradi, Vasyl Sava , Juan Sanchez-Ramos
USF Research Day 2013
Nanoparticles for Delivery of DNA and siRNAinto Brain by Nasal Insufflation

Sava V, Aradi S, Song S, Sanchez-Ramos J
presented at International Symposium on HD, Venice Italy April 2013
35
Effects of Bone Marrow Transplantation in a Mouse Model of HD

Song S, Sava V and Sanchez-Ramos J
presented at International Symposium on HD, Venice Italy April 2013
Funded Research (Investigator-initiated Grants within past 10 years):
(1999-2004) Sanchez-Ramos, PI, VA Merit “Stem Cells as a source of DA Neurons for Brain
Repair” ($631,200 total)
(1998-2001) Sanchez-Ramos, PI, “Human Bone Marrow Cells as a Source of Neural Tissue”
funded by Layton Biosciences, Inc. ($100,000/yr)
PI, “Human Umbilical Cord Blood as a Source of Neural Tissue” funded by CryoCell, Inc. and
State of Florida ($150,000)
(2001-2002) Sanchez-Ramos, PI, “Neural Stem Cells from Umbilical Cord Blood” NIH STTR
Grant (1st year 100,000).
(2002-2007) Sanchez- Ramos, Co-Investigator 10% effort (PI is Tanja Zigova). “Potential of
Cord Blood Cells to Rescue Aging Brain” NIH ($900,000 five years).
(2003-2008) Sanchez-Ramos, PI. “DNA Damage and Repair in the Aging Brain” Competitive
Renewal VA Merit Review ($850,000 4/2003 to 3/2008)
Sanchez-Ramos, Co-Investigator “PD Neuroprotection Clinical Trial: Clinical Centers” NIH

1U10 NS44425-01 $106,575 (1st year)
(2003-2006) Sanchez-Ramos PI “The Brain’s DNA Repair Response to Neurotoxicants”

Department of Defense ($950,000 for 3 years)
(2006-2007) Sanchez-Ramos, J. PI “Generation of New Neurons in Adult Hippocampus by

Overexpression of NeuroD1” Florida Alzheimer’s Disease Research Center ($54,000)
(2005-2010) PIs H. Potter and R. Duara (J. Sanchez-Ramos is Investigator in the Clinical
Core) “Trajectory of Cognitive Decline in Subjects with MCI” Funding source: NIH (NIA)
(2008-2112) PI S. Song; Co-PI J. Sanchez-Ramos. “Function and Fate of Nestin-Expressing

Stem Cells Derived from Adult Brain and Bone Marrow” Funding Source VA Merit
(2007-2010) Sanchez-Ramos, J. PI “Bone Marrow-Mobilizing Drugs for Treatment of

Alzheimer’s Disease” Elan-Alzheimer’s Disease Research Foundation ($272,000)
(2009-2014) Sanchez-Ramos, J PI “Mechanisms of Action of Filgrastim in a Mouse Model of
36
AD” VA Merit Grant (Total direct costs=$750,000).
(2012-2014) Sanchez-Ramos, J PI “G-CSF for Treatment of Traumatic Brain Injury in

Veterans” Funded by DOD (sub-project II, $200,000).
(2015-2020) PI: J Sanchez-Ramos (30% effort) 10/1/2015- 9/30/20

Source: NIH RO1 NS095563-01
Title: Nanocarriers Designed to Deliver Nucleic Acids to Brain
Total Direct Costs 1,161,729 (total costs $2,466,557
Objectives: To optimize nanocarrier system in cell cultures; To test optimized nanocarriers
loaded with siRNA against a marker gene expressed in a mouse model of Huntington’s
Disease; To test the hypothesis that extrusion into the cell culture media of exosomes
containing residual, smaller mNPs into the extracellular fluid may play a role in their
dissemination from cell to cell.
Patents:
Mash D, Sanchez-Ramos J, and Hearn L.

“A Method of Treating Chemical Dependency in Mammals and A Composition Thereof”
United States Patent Office (Awarded Feb 19, 2002) # 6,348,456
Sanchez-Ramos, J, S. Song, P. Sanberg, W. Janssen, T. Freeman.

“Bone Marrow Cells as a Source of Neurons for Brain and Spinal Cord Repair”
United States Patent Office (Awarded March 3, 2003 # 6,528,245 B2
Sanberg, P, Sanchez-Ramos J, Willing A, Richard, DD.

“Human Cord Blood As A Source Of Neural Tissue For Repair Of The Brain And Spinal Cord”
United States Patent Office (Awarded Jan 9, 2007 Patent # 7,160,724 B2)
Sanchez-Ramos, J. Richard Heller and Mark Jaroszeski. “Nervous Tissue Electrode Device”
United States Patent Office (Awarded July 19, 2007 Patent # 0167903 A1
Sanchez-Ramos, J. Song, S. and Sanberg, P.

“Novel Cellular Delivery into the Central Nervous System of Brain and Atrial Natriuretic
Peptides”
United States Patent Office (pending)
Filed: September 6, 2002
Sanchez-Ramos J, S. Song, C. Cao, G. Arendash “Method of Treating Alzheimer's Disease

with Granulocyte Colony Stimulating Factor (G-CSF)” submitted to US Patent Office, USF Ref.
No. 08A003PR
Song S, Sanchez-Ramos J. “Promotion of Brain Self-Repair by Stereotaxic Micro

Stimulation” US Pat 8,452,408
37
Sanchez-Ramos, J Sava, V, Song S, Mohapatra, S. Divalent-Metal Coated Nanoparticles

For Delivery Of Compositions Into The Central Nervous System By Nasal Insufflation U.S.
Provisional Patent Application Serial Number 61/534,417
Editorial responsibilities:
1. Member of International Board of Editors of Movement Disorders (1994-1999)

2. Associate Editor for Yearbook of Neurology and Neurosurgery (1995-2005)
3. Ad hoc reviewer for Neurology, Journal of Neurochemistry
Movement Disorders, Glia, Experimental Neurology, Brain Research, Cell Transplantation
4. Editor, Parkinson Update, Medical Publishing Co., Philadelphia PA
5. Co-Editor-In-Chief, Gene Expression, Cognizant Publishing, Inc. New York, NY (2002-
2006)
NIH Grant Reviews: ad hoc reviewer since 1995; member of CNNT Study Section (2005-2010)
Society Memberships:
American Academy of Neurology

American Neurological Association
American Association for the Advancement of Science
International Society of Stem Cell Research
Movement Disorder Society
Oxyradical Society
Research Societies: Parkinson Study Group and Huntington's Disease Study Group
Society of Environmental Toxicology and Chemistry (SETAC)
Honors and Awards:
NIH pre-doctoral fellowship, Dept of Pharmacological and Physiological Sciences, University of

Chicago, (1971-1976)
James Scholar Program of Independent Studies, University of Illinois College of Medicine

(1978-83)
Bertram A. Richardson Foreign Scholarship (1981)
Clinical Investigator Development Award (NIH) 1989-1991
"Prix de la qualite de la Realisation technique" awarded during Concours International des

Technolgie de la Creation held in Paris, 19 November, 1991 for hologram entitled "Crystal
Dreams"
38
Helen E. Ellis Endowed Chair in Parkinson’s Disease Research (1996)
University of South Florida Outstanding Research Award for nationally recognized research on
transdifferentiation of bone marrow stromal cells to neural cells (2003)
Award for animation entitled “Dancing DNA” sponsored by the University of Chicago Materials
Research Center in their annual Sights and Sounds of Science Project (2004)
Post Doctoral Training
1. Post-doctoral fellowship in Behavioral Pharmacology, University of Ottawa, Canada funded

by the Medical Research Council of Canada, Non- Medical Use of Drugs Directorate
(1976-77); Preceptor: Prof. R. Stretch
2. Post-doctoral fellowship in Pharmacology, University of Chicago, Dept. of Pharmacology
funded by an NIH Institutional Training Grant (1977-78) Preceptor: Prof. L. J. Roth
3. Internship in Internal Medicine, Michael Reese Hospital, Chicago (1981-82)
4. Residency Training in Neurology, University of Chicago, Dept. of Neurology (1982-85)
Chairman: Prof. Barry Arnason
5. Movement Disorder Fellowship, Dept. of Neurology, University of Miami (1985-87)
Preceptors: Profs. W. J. Weiner and F. Hefti
Other Professional Activities:
a. Medical Illustrations for books:

"Stroke: A Clinical Approach" by L. Caplan and R. Stein, Butterworths, Boston, London (1986)
and second edition (1992)
“Posterior Circulation Vascular Disease” by L. Caplan, Blackwell Science, Boston (1996)
b. Selected Scientific Presentations at National and International meetings:
Sanchez-Ramos, J.R., and C.R. Schuster. Naloxone-precipitated abstinence in the rhesus

monkey: comparison of the intracerebral and intravenous routes of morphine-antagonist
administration. Presented to the Committee on Problems of Drug Dependence of the National
Research Council (Satellite Session on Drugs as Reinforcers) May 18, 1975, in Washington,
D.C.
Sanchez-Ramos, J.R., and C.R. Schuster. Second Order schedules of morphine and cocaine
reinforcement. Presented at the APA meeting Aug. 30, 1975, Chicago
Sanchez-Ramos, J.R., Barrett, J.N., Weiner, W.J., and Hefti, F. Effects of MPTP and MPP+ on
dopaminergic neurons in cultures of rat mesencephalic cells. Presented at the American
Academy of Neurology Conference, April 1986, New York, NY
Sanchez-Ramos, J. R. Factor, S.A., Weiner, W.J. Vitamin E Therapy in Parkinson's Disease.

Presented at 9th International Symposium on Parkinson's Disease, Jerusalem, June 1988
39
Sanchez-Ramos, J.R., Factor, SA, Macalarney T, Weiner WJ. The Effects of Sleep on Motor
Symptomatology In Parkinson's Disease Presented at the 9th International Symposium on
Parkinson's Disease, Jerusalem, June 1988
Levin, B.E., Llabre, M.M., Ansley, J., Sanchez-Ramos, J.R.,

Weiner, W. J. Visuospatial dysfunction in Parkinson's disease Presented at 9th International
Symposium on Parkinson's Disease, Jerusalem, June 1988
Sanchez-Ramos, J. R. Effects of MPP+ and Several Structural Analogs on Dopamine

Neurons in Culture. Presented at Symposium on Degeneration and Regeneration Processes,
Sardinia, Sept., 1988
Weiner WJ, Sanchez-Ramos J, Singer C, Mash D, Sheldon C. Cornelius L, Ingenito A. The

aircraft industry and Parkinson's disease- Any relationship? Presented at the Symposium on
Hyperkinetic Movement Disorders (Sponsored by the Parkinson Study Group and the
Movement Disorders Society) New Orleans, Louisiana, Sept, 1989
Bejany D, Lynne C, Singer C, Sanchez-Ramos J, Weiner WJ, Ackerman M, Politano VA.

Sexual and voiding dysfunction in Parkinsonian men. Presented at the Southeastern Section of
the American Urological Association, Hilton Head, South Carolina, April, 1989
Sanchez-Ramos, J. R. and Watson B. "Early Detection of Lipid Peroxidation Products in

Cultures of Dopamine Neurons Exposed to MPP+". European Conference on Parkinson's
Disease, Rome, Italy, July 9-14, 1990
Sanchez-Ramos, J. R., Weiner WJ, Pressman B. "Alterations in platelet membrane rigidity in

Parkinson's disease" presented at AAN in Boston, April, 1991
Sanchez-Ramos, J. R., "Advances in Parkinson's Disease Research", presented in Valera,

Venezuela, sponsored by the Venezuelan Association of Neurology, April, 1992
Sanchez-Ramos, J. R.. Potential cytotoxicity of norcocaine for developing dopaminergic

neurons. Presented in platform session during AAN meeting in San Diego, CA, May, 1992
Sanchez-Ramos, J. R. Acute effects of MPP+ on ATP production in mesencephalic cultures of

dopaminergic neurons: protection by 21-aminosteroids. Presented in platform session during
AAN meeting in San Diego, CA May, 1992
Sanchez-Ramos, J. R. A marker of oxyradical-mediated DNA damage (oxo 8dG) is increased in

the nigro-striatum of Parkinson's Disease brain. Presented at Symposium on the Etiology,
pathogenesis of Parkinson's Disease. Boston, MA, Oct 1993
Sanchez-Ramos JR. Ibogaine and its potential for treatment of cocaine dependence Ninth
Annual Stanford Health Policy Forum, Palo Alto, CA April, 1995
40
Sanchez-Ramos, J. R. Oxyradicals and Neurodegnerative Diseases. International Symposium

on Oxyradical in Medicine. Buenos Aires, (Sept 6, 1995)
Sanchez-Ramos J. R. Dieldrin and Parkinson's Disease. Environmental Factors and

Parkinson's Disease, A Symposium sponsored by the NIEHS, Research Triangle, North
Caroline, ( Sept 18, 1995)
Sanchez-Ramos, J. R. Banisterine and Parkinson’s Disease. International Conference on

Hoasca sponsored by UDV in Rio de Janeiro, Brazil, Nov 2-4, 1995
Sanchez-Ramos J. Scientific highlights, Movement Disorders. Presented at Annual meeting

of American Academy of Neurology, San Francisco, March 28, 1996
“Pergolide monotherapy in early and late Parkinson’s disease” presented to Association of

Danish Neurologists in Toruplund, Denmark , April 12, 1996
“Pergolide monotherapy in advanced Parkinson’s disease” presented to Finnish Neurology

Group in Amsterdam, Netherlands, April 15, 1996
“High dose dopamine agonist therapy in Parkinson’s disease” Experts Symposium on

Dopamine Agonists, Barcelona, Spain. Oct. 26, 1996
“Stem Cells as a Source of Dopaminergic Neurons” platform session presented at

Symposium on the Etiology, Pathogenesis and Treatment of Parkinson’s Disease”, Sept
1997, San Diego.
“Organochlorine Pestcides and Parkinson’s Disease” Sept 15, 1998; 16 th International

Neurotoxicology Conference, Little Rock Arkansas.
“Pharmacotherapy of Parkinson’s Disease” August 20, 1998 Lily of Denmark Symposium on

PD. Telfs-Buchen, Austria
“Bone marrow stromal cells as a Source of Neural Tissue” presented at a platform session at
American Academy of Neurology Annual Meeting in Toronto, Canada, April, 1999
“Pesticides and Parkinson’s Diseases” presented at the ISN/ESN satellite symposium on

Neurotoxic Factors in Parkinson’s Disease and Related Disorders, Ulm, Germany August 6,
1999
“High Dose Pergolide Therapy for Complex Motor Fluctuations” Presented at Pergolide
Global Medical Conference, Barcelona, June 10, 2000
“Adult Bone Marrow Stromal Cells as a Source of Neural Cells” American Society for Neural
Transplantation and Repair, April 28, 2000 Clearwater, FL
41
“Parkinson’s Disease Research Update” invited lecture at University of Basel, Basel

Switzerland, Jan 25, 2001
“Advances in Huntington’s Disease” invited lecture at University of Basel, Basel Switzerland,

Jan 26, 2001
“Molecular and Cellular Evidence for Neural Progenitors in Human Umbilical Cord Blood
Neurology” Platform presentation at AAN meeting in Philadelphia, May, 2001
“Neural Gene Expression in Human Umbilical Cord Blood Cells” Platform presentation at
American Society for Neural Transplanation and Repair in Clearwater, FL May, 2001
“Neural Progenitors from Human Umbilical Cord Blood” presented at Royal Society meeting
on Stem Cells June 21, 22, 2001 (London, UK) .
“Bone Marrow and Umbilical Cord Blood as a Source of Neural Cells” Invited lecture
presented during a special session on Stem Cells and their Niche 5 th Vascular Biology
Conference held in Osaka, Japan on Aug 2-5th, 2002,
Three invited lectures presented at The Jiao Tong University School of Medicine in the ancient
capital of China, Xian, “Stem Cells, Basic Concepts and Experimental Studies”, “Stem Cells
Derived from Adult Tissues” and “Separation of Neural Progenitors from mixed populations of
bone marrow cells or umbilical cord blood”.
Invited Lecture “Clinical Aspects of Parkinson’s and Huntington’s Disease” to introduce the
Neurobiology of Disease Workshop Stem Cells for Neurodegenerative Diseases . Presented
at the 32 Annual Meeting of the Society for Neuroscience, Orlando FL Nov 2, 2002
Invited Lecture “Neurodegenerative Diseases: Disorders of Protein Misfolding?” Annual

Meeting of the Mexican National Institute of Neurology and Neurosurgery, held in Acapulco,
Mexico June 6, 2003
Invited Lecture “Scientific Advances in Cell-Based Therapy for Brain Injury” Conference on
Brain Injury: the Rehabilitative and Neuropsychiatric Interface. Held in Clearwater, FL;
Sponsored by USF and Dept of Veteran Affairs, James Haley VA, Tampa FL Nov. 7, 2003
Platform presentation at the 18th Annual Symposium on the Etiology, Pathogenesis and
Treatment of Parkinson’ Disease. Oct., 2004 in Toronto Canada. “The Ubiquitous Mycotoxin
Ochratoxin B Causes Dopamine Depletion and Alterations in Oxidative DNA Repair in
Striatum”
World Congress of Neurology (Sydney, Australia, Nov 6, 2005). Teaching Course on

Neurotoxicology:
“Toxic Exposure: Precursors to Neurodegenerative Disease”
World Congress of Neurology (Sydney, Australia, Nov 6, 2005). Teaching Course on
42
Neurotoxicology:
“Manganese and Parkinsonism”
World Congress of Neurology (Sydney, Australia, Nov 7, 2005). Plenary Session on Terrorism
and the Neurologist: “Mycotoxins: Low level exposure and subsequent parkinsonism”
9th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy (April 19,

2006) Invited speaker: “Role Of Neuro D1 In The Generation Of New Neurons In The Adult
Brain”
SETAC 17th Annual Meeting in Portgual, Platform presentation (May 24, 2007) “Quantitative
Tremor Analysis in Welders, Parkinson’s Disease and Essential Tremor”
8th International Conference on Alzheimer’s Disease Drug Discovery October 15-16, 2007
“Potential of Hematopoietic Agents for Treatment of Alzheimer’s Disease”.
9th International Conference on Alzheimer’s Disease Drug Discovery Oct 2-3. 2008 “G-CSF
Reduces Brain Amyloid, Increases Expression of Synaptophysin and Improves Cognition in a
Mouse Model of Alzheimer’s Disease”
Society for Neuroscience, Washington DC Nov 18, 2008 “Filgastrim (G-CSF) increases
hippocampal neurogenesis”,
10th Annual VA/USF Falls Conference, Clearwater FL, May 6, 2009 Invited Speaker:
“Parkinson’s Disease and Fall Risk”
International Society for Stem Cell Research 7th Annual Meeting July 8-11, 2009 Barcelona, FL
“Effects of G-CSF on Mouse Hippocampal Neurogenesis”
Invited lecture: Horizons: Perspectives on Psychedelics 2011, New York, NY. “Effects of
Psilocybin and other Serotonin agonists on Hippocampal Neurogenesis”.
http://vimeo.com/33812651
Invited lecture: Eckerd College Presidential Events Series. 2012. St. Petersburg, FL. “Neon
Neurons”
Key Note Speaker: “Art and Science: a Neurologist’s Perspective” sponsored by Tampa Bay
Society for Art and Culture: Oct 24, 2012 at the Tampa Museum of Science and Industry.
Invited speaker “Nose-to-Brain Delivery of Gene Therapy” (Data Buzz presentation) Milton
Wexler Celebration of Life (HD Conference, Cambridge, Mass Aug 2014)
Key-note Speaker for the Performing Arts Medical Association (June 2016, Weil Cornell
College of Medicine, New York) “Neuroplasticiy in Musicians’ Dystonia”
c. Continuing Education Lectures (not listed)
43
d. Consultantships:
Neurological Consultant for the USA-Venezuela Huntington's Disease Project (1987 -1996)
Neurological Consultant for Upfront, a clearinghouse for drug abuse information, Miami,
Florida (1988-1996)
Neurological Consultant for National Parkinson Foundation (1988-1996)
Neurological Consultant to Elan Pharma (1993- 1995)
Consultant to NTI (Neurobiological Technologies Inc) of San Francisco, CA (1996)
Consultant to Smith Kline-Beetcham (1996-1999)
Consultant to Layton Biosciences, Inc (1997-2001)
Consultant to Saneron-CCELL Biotherapies, Inc. (2002-2003)
Consultant to NewNeural, Ltd. (2003-2005)
Consultant to Lundbeck, Inc (2009- 2002)
TEACHING
Current and Past Teaching Responsibilies:
1976-77: Lectures on Biological Basis of Drug Dependence and Behavioral Pharmacology to

Graduate students in Dept of Psychology, University of Ottawa, Canada
1984-85: Lectures in Neuroanatomy in the Neuroscience course for medical students,
University of Chicago
1987-96: Lectures on Movement Disorders to students in PhD to MD program, University of
Miami; Coordinator of Neurology lectures in the "Mechanisms of Disease" course for second
year medical students; Grand Rounds in Dept of Neurology; Clinical teaching to medical
students and housestaff in Outpatient Clinic; Bedside teaching and supervision of housestaff in
the Neurology Ward at Jackson Memorial Hospital
1996- : Neuroscience lectures on motor control (1 st year Medical Student course in
Neurosciences) USF College of Medicine; Neurology Seminars on Movement Disorders to
Neurology Residents and Medical Students; Clinical teaching to medical students and
housestaff in Movement Disorder Clinic; Bedside teaching and supervision of housestaff in the
Neurology Ward at Tampa General Hospital; Teaching residents in Neurology and interns in
Pharmacy in the outpatient Parkinson’s Disease Clinic James Haley VA.
Seminars on neurodegeneration, stem cell biology and neuronal differentiation to Depts of
44
Anatomy, Biochemistry, Pharmacology, Neurosurgery, and Psychiatry.

Lectures in Movement Disorders (4 hrs) as an intoduction to pathological-clinical relationships
to 1st year medical students in the Neurosciences Course.
Thesis advising: PhD Thesis advisor for Graduate Students in Dept of Pharmacology: Todd
Stedeford, PhD (2001), Chris Hazzi, MS (1998), Briony Catlow,PhD (2008); Amanda Rowe
(MD/PhD candidate).
SERVICE
Departmental and University Administrative Responsibilities:
Departmental coordinator of CME credits for Neurology and Neuropathology Grand Rounds
(1988-1990)
Medical School Task Force for a Drug-Free Environment (University of Miami)
Task Force on "Access to Neurological Care" of the American Academy of Neurology

(1989-1993)
Member of Faculty Senate, University of South Florida (1997- 2002)
LCME Graduate Student Education Committee (USF-COM) (1997-98)
Member of Research Committee of the USF College of Medicine (1997-1999)
Member of James Haley VA Research Service Scientific Review Committee (1996- 2001)
Member of College of Medicine Space Committee (1998-2000)
Member of Faculty Council, USF HSC (2000-2002)
Member of Promotion and Tenure Committee, USF (2000- 2003)
Faculty Liaison to the Workgroup on Research and Scholarship Committee of the University of
South Florida Board of Trustees (2002- )
Secretary of Faculty Council College of Medicine, University of South Florida (elected 2003-
2005)
Medical Director of Parkinson Research Foundation (Non-Profit) 2008-
Vice-Chairman for Research Dept of Neurology, University of South Florida (2006- )
Member of IRB Committee A (2015-16)
45

9497

Uploaded by

Copyright:

Available Formats

9497

Uploaded by

Document Information

Original Description:

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

9497

Uploaded by

Copyright:

Available Formats

CURRICULUM VITAE Juan R.

Date: March, 2016

Office Address: Home Address:

Office phone: (813)974-5841 Home Phone: 813-986-9044

Current academic rank: Professor Primary Department: Neurology

University of Chicago, Dept. of

University of Illinois, College of Medicine, Chicago............MD 1981 (Medicine)

2. Sanchez-Ramos J and Weiner WJ. Iatrogenic Movement Disorders, In "Neurology for

3. Sanchez-Ramos, J. Neurological Emergencies Related to Drugs of Dependence, In,

4. Sanchez-Ramos, J and Weiner WJ. Drug-induced tics. In Handbook of Tourette's

5. Sanchez-Ramos, J. and Weiner W. J. Other Dopaminergic Drug-induced Movement

6. Sanchez-Ramos, J. Toxin-induced parkinsonism. In: Parkinsonian syndromes (Ed. M.

7. Sanchez-Ramos, J. Psychostimulants. In, Neurologic Clinics, Neurologic

9. Globus MYT, Prado R, Sanchez-Ramos J, Dietrich WD, Ginsberg MD, Busto R.

10. Shulman LM, Sanchez-Ramos J, Weiner WJ. Stereotyped Behavior in Movement

11. Sanchez-Ramos, J. and Mash D. Pharmacotherapy of drug dependence with ibogaine.

12. Sanchez-Ramos, J. Neurological Complications of Drugs of Abuse, In Neurology in

13. Sanchez-Ramos, J. High dose pergolide therapy in the treatment of severe

14. Sanchez-Ramos, J. Motor Complications of Levodopa therapy, In, Parkinson’s

18. Sanchez-Ramos J. Stimulant-Induced Movement Disorders, In, Drug-Induced

19. Carroll, E and Sanchez-Ramos J. Hyperkinetic Movement Disorders Associated with

20. Sanchez-Ramos, J. Discrepancy in CAG Repeat Lengths in a Case of Clinically

21. O’Neill C and Sanchez-Ramos J. Cannabinoids for the treatment of Movement

B. SCIENTIFIC ARTICLES IN REFEREED JOURNALS

24. Stretch, R. and Sanchez-Ramos, J.Effects of morphine, naloxone, and

25. Sanchez-Ramos, J. and Senay, E. Ophthalmic naloxone elicits abstinence in

28. Sanchez-Ramos, J., G. E. Hollinden, T. J. Sick, and M. Rosenthal. MPP+ increases

30. Sanchez-Ramos J, Michel P, Weiner WJ, Hefti F. Selective Destruction of Cultured

36. Weiner, W.J., Factor, S.A., and Sanchez-Ramos, J. The efficacy of

37. Sanchez-Ramos J, Factor SA, Weiner WJ. Hemichorea-ballismus associated with

46. Sanchez-Ramos, J. Banisterine and Parkinson's Disease. Clinical Neuropharm

54. Duyao et al (with the USA-Venezuela HD group including Sanchez-Ramos, J.)

58. Fleming L, Mann JB, Briggle T, Sanchez-Ramos J. Organochlorine pesticides in

59. Sanchez-Ramos J, Overvik E, Ames BN. A marker of oxyradical-mediated DNA

61. Verma A, Berger J, Sanchez-Ramos J Reversible Parkinsonian Syndrome Associated

65. Facca A, and Sanchez-Ramos, J. Pergolide monotherapy in complicated Parkinson's

66. Sanchez-Ramos J, Ortoll R, Paulson G. Visual hallucinations in Parkinson's disease

67. Sanchez-Ramos J, Song S, Basit A, Epstein CJ. Transgenic Murine Dopaminergic

68. Sanchez-Ramos J. Facca A, Basit A, Song S. Toxicity of dieldrin for dopaminergic

69. Cardozo-Pelaez F, Song S, Parthasarathy A, Epstein CJ, Sanchez-Ramos, J.

70. Cardozo-Pelaez F, Song S, Parthasarathy A, Naidu K, Sanchez-Ramos, J. Oxidative

72. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A,.

73. Sanchez-Ramos J, S. Song, M. Dailey, F. Cardozo-Pelaez, C. Hazzi, T. Stedeford, A.

74. Sanchez-Ramos J, S Song, M. Daadi, P. R. Sanberg. The Potential of Bone Marrow

75. Stedeford T, Cardozo-Pelaez F, Hover C, Harbison RD, and Sanchez-Ramos J.

78. Serrano-Duenas M, F. Cardozo-Pelaez, J. Sanchez-Ramos. Effects of Banisteriopsis

79. Stedeford T, Cardozo-Pelaez F, N. Nemeth, Harbison, J. Sanchez-Ramos.

81. Sanchez-Ramos J, Song S, Kamath S, Zigova T, Willing A, Cardozo-Pelaez F,

82. Chen, J. Sanberg P. R. Li Y. Wang L. Lu M. Willing A. E. Sanchez-Ramos J., Chopp M

89. Mosquera D, Stedeford T, Cardozo-Pelaez F, Sanchez-Ramos J Strain-Specific

94. Song, S. Kamath S, Mosquera D, Zigova T, Sanberg P, Vesely DL, Sanchez-

95. V. Sava, D. Mosquera, S. Song, F. Cardozo-Pelaez, and J. Sanchez-Ramos Effects Of

96. The US-Venezuela Collaborative Research Project (and J. Sanchez-Ramos)

97. Sava V, Mosquera D, Song S, Stedeford T, Calero K, Cardozo-Pelaez F, Sanchez-

104. Zesiewicz TA, Sanchez-Ramos J, Sullivan KL, Hauser RA. Levetiracetam-Induced

110. Sava V, Reunova O, Velasquez A, Sanchez-Ramos J. Acute Neurotoxic Effects of the

111. Sava V, Reunova O, Velasquez A, Sanchez-Ramos J. Can low level exposure to

113. Sava V, Velasquez A, Song S, Sanchez-Ramos J. Adult Hippocampal Neural

114. Sava V, Velasquez A, Song S, Sanchez-Ramos J. Dieldrin elicits a widespread DNA